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Abstract
Survival and persistence of Mycobacterium avium subsp. paratuberculosis (MAP) in the intestinal mucosa is associated with
host immune tolerance. However, the initial events during MAP interaction with its host that lead to pathogen survival,
granulomatous inflammation, and clinical disease progression are poorly defined. We hypothesize that immune tolerance is
initiated upon initial contact of MAP with the intestinal Peyer’s patch. To test our hypothesis, ligated ileal loops in neonatal
calves were infected with MAP. Intestinal tissue RNAs were collected (0.5, 1, 2, 4, 8 and 12 hrs post-infection), processed, and
hybridized to bovine gene expression microarrays. By comparing the gene transcription responses of calves infected with
the MAP, informative complex patterns of expression were clearly visible. To interpret these complex data, changes in the
gene expression were further analyzed by dynamic Bayesian analysis, and genes were grouped into the specific pathways
and gene ontology categories to create a holistic model. This model revealed three different phases of responses: i) early
(30 min and 1 hr post-infection), ii) intermediate (2, 4 and 8 hrs post-infection), and iii) late (12 hrs post-infection). We
describe here the data that include expression profiles for perturbed pathways, as well as, mechanistic genes (genes
predicted to have regulatory influence) that are associated with immune tolerance. In the Early Phase of MAP infection,
multiple pathways were initiated in response to MAP invasion via receptor mediated endocytosis and changes in intestinal
permeability. During the Intermediate Phase, perturbed pathways involved the inflammatory responses, cytokine-cytokine
receptor interaction, and cell-cell signaling. During the Late Phase of infection, gene responses associated with immune
tolerance were initiated at the level of T-cell signaling. Our study provides evidence that MAP infection resulted in
differentially regulated genes, perturbed pathways and specifically modified mechanistic genes contributing to the
colonization of Peyer’s patch.
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Introduction
Mycobacterium avium subsp. paratuberculosis (MAP) causes a chronic
enteric infection (Johne’s disease) in cattle and other ruminants
that is established after ingestion of bacteria followed by invasion
and colonization of the intestinal mucosa. The major hurdle in
understanding MAP infection is its chronic nature and delayed
onset of clinical symptoms. Much is known regarding the host
response of chronically infected cattle, but the understanding of
the early events in the host is limited. In the jejunal-ileal Peyer’s
patches, MAP gain entry in intestinal mucosa via interaction with
M cells, goblet cells, epithelial cells, dendritic cells or macrophages
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[1–3]. Lesions that are characterized by aggregates of macro-
phages, epithelioid cells, and giant cells develop in the intestinal
mucosa of experimentally infected neonatal calves within 5 months
[4]. Moreover, systemic humoral and cellular immune responses
develop within months after instillation of MAP into the tonsillar
crypts of neonatal calves [5]. Mononuclear cells isolated from the
intestine of cows subclinically infected with MAP showed a state of
tolerance [6,7]. Several studies have focused on the role of
circulating mononuclear phagocytes during MAP infection [8–12].
It appears that mucosal immunological tolerance is required for
persistent infection. However, the outcome of the host-pathogen
interaction depends on the collective response of various cell types
that are present at the mucosal surface. Additionally, knowledge of
which components of the host response are involved in the
activation of innate immunity is poorly understood in chronic
infections. Thus, more comprehensive knowledge is needed
regarding the pathogen interaction within the host milieu of the
natural site of infection. Toward this goal, we have successfully
established the perinatal calf ligated ileal loop model for studying
early changes in the mucosa during MAP infection [2].
About 65% of U.S. herds are infected with MAP [13]. This level
of infection definitely leads to contamination of the environment via
contaminated water supply, dust bio-aerosol, milk and food supply.
This contaminated environment not only affects the spread of MAP
among animals, it may also be associated with the human intestinal
disorder, Crohn’s disease [14–18]. Interestingly, MAP has been
isolated from intestinal tissue, as well as, peripheral blood of human
patients suffering with a similar granulomatous inflammatory
disease known as Crohn’s disease [19]. Several pathogens, including
MAP, have been claimed to be associated with the Crohn’s disease
in human [20,21]. Like Johne’s disease, Crohn’s disease also affects
a pediatric population. In a recent study, identification of MAP in
gut tissue and blood from pediatric inflammatory bowel disease
patients suggests the possible involvement of MAP in the early stages
of development of Crohn’s disease in children [22]. Crohn’s disease
is likely to be more than one disease, which complicates research.
Furthermore, microbial contact or invasion may be confined to
parts of the alimentary tract that are relatively inaccessible to tissue
sampling, such as the ileum or jejunum. The in vivo perinatal calf
jejunal-ileal loop model provides an ideal animal model to more
precisely study the early pathogenesis of MAP or other microbial
pathogens in Crohn’s disease.
In the present study, we hypothesized that MAP induces an
immune tolerance in Peyer’s patch very soon after invasion. To
test our hypothesis, we analyzed the temporal gene expression in
detail during the early stages of colonization of Peyer’s patch by
MAP. We applied a systems biology approach to analyze the
complex microarray data enabling us to identify specific cellular
pathway perturbations and predicted cell type involvement during
the early infection and colonization. Furthermore, we identified
innate response signatures (mechanistic genes) adequate to
envisage the subsequent adaptive immune responses leading to
persistent MAP infection. The aims of this study were two fold, 1)
to utilize a systems biology analytical approach to gain new
insights regarding the most perturbed cellular pathways; and 2) to
provide evidence for tolerance related components of mucosal
immunity during early MAP infection.
Materials and Methods
Culture of MAP
Mycobacterium avium subsp. paratuberculosis (ATCC 19698) from
American Type Culture Collection (ATCC), Manassas, VA, was
grown aerobically in 7H9 broth (Difco Laboratories, Detroit, MI)
supplemented with 2.5% (vol/vol) glycerol (Sigma Chemical Co.,
St. Louis, MO), oleic acid-albumin-dextrose-catalase (Difco
Laboratories, Detroit, MI), 0.05% Tween 80 (Sigma Chemical
Co., MO), and 2 mg/liter of Mycobactin J (Allied Monitor, Inc.,
Fayette, MO). Single-cell suspensions and enumeration of MAP
were done as described earlier [23].
Animals
Four clinically healthy male, unrelated Holstein-Friesian calves,
3–4 weeks of age and weighing 45–55 kg, were used in the
experiment under an approved animal use protocol in accordance
with animal use policy under the supervision of the Texas A & M
University Institutional Animal Care and Research Advisory
Committee (AUP 2007-70). The calves were fed antibiotic-free
milk replacer twice daily and water ad libitum. All of the calves were
tested for the presence of Salmonella spp. and MAP. Fecal
specimens and rectal swabs were collected from calves two weeks
prior and immediately before the experiment. Fecal specimens
were prepared for the PCR for detection of MAP [23] and culture
based detection of Salmonella [24]. Only calves with negative tests
for these pathogens were used in these experiments.
Bovine Ligated Jejunal-Ileal Loop Surgery
The calves were fasted for 24 hrs prior to the non-survival
surgery, anesthetized and maintained analgesic for the course of
the 12 hrs experiment. In brief, anesthesia was induced with
Propofol (Abbot Laboratories, Chicago, IL) followed by placement
of an endotracheal tube and maintenance with isoflurane (Abbot
Laboratories, Chicago, IL) for the duration of the experiment. The
detailed bovine ligated ileal loop surgery procedure is described
elsewhere [2]. Loops were prepared exclusively in the 1.0–
1.2 meter long Peyer’s patch that is proximal to the ileocecal
junction and included jejunum and ileum. Loops were inoculated
with 3.0 ml of PBS or 36109 cfu of MAP in 3.0 ml of PBS. At 0.5,
1, 2, 4, 8 and 12 hrs after inoculation, one each of control (PBS
inoculated) and experimental (MAP inoculated) loops were
excised. Samples for bacteriologic culture and RNA extraction
were collected as described below. Throughout the experimental
procedure, the calves were monitored for vital signs (blood
pressure, heart rate, hydration status, anesthesia depth and
temperature). The calves were euthanized with a rapid overdose
(single bolus at 60 mg/lb IV) of pentobarbital sodium after the
final samples were collected at 12 hrs post-inoculation.
Bacteriology
A 6 mm biopsy punch was used to collect two intestinal mucosal
samples from each loop of Peyer’s patch for bacteriology. Intestinal
biopsy samples were washed three times in PBS, weighed, placed in
the Whirl-PakTM bag, homogenized in a Colworth-Stomacher
blender in PBS, and serially diluted. The tissue extracts were plated
onto Herrold egg yolk media containing amphotericin, nalidixic
acid, vancomycin (Becton Dickinson and Company, Sparks, MD)
with or without Mycobactin J and incubated at 37uC. The cultures
were observed visually weekly for any contamination, and the final
counts of colony forming units were recorded on week 16.
Extraction and Quality Analysis of RNA
A 6 mm biopsy punch was used to collect 8 intestinal mucosal
samples (at each time) of Peyer’s patch from the excised PBS
control and MAP infected loops for the extraction of RNA at 0.5
1, 2, 4, 8, and 12 hrs post-infection. The tissue was immediately
minced with a scalpel blade and transferred to TRI ReagentTM
(Molecular Research Center, Cincinnati, OH). Two biopsy
Paratuberculosis-Immunotolerance, Mucosal Barrier
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punches (approximately 0.1 mg of tissue) were placed into 0.5 ml
of TRI reagentTM. Tissues were further disrupted with hand-held
mechanical tissue grinder equipped with a RNase, DNase free
plastic disposable pestle. The RNA extraction was done using the
recommended protocol from the manufacturer (Molecular Re-
search Center, Cincinnati, OH). The resultant RNA pellet was re-
suspended in DEPC-treated water (Ambion, Austin, TX).
Genomic DNA was removed by RNase-free DNase I treatment
(DNA-free, Ambion) according to the manufacturer’s instructions,
and samples were stored at 280uC until used. RNA concentration
was quantified by measuring absorbance at l260 nm using a
NanoDropH ND-1000 (NanoDrop, Wilmington, DW). RNA
quality was evaluated by measuring ratio of absorbance at
l260 nm to absorbance at l280 nm, agarose gel electrophoresis,
and using a Nano-ChipH on an Agilent 2100 Bioanalyzer (Agilent,
Palo Alto, CA). All the RNA samples used in this study were of
good to excellent quality (results not shown), and had distinct 18S
and 28S rRNA peaks and RNA size distribution. Ten mg of this
high quality experimental RNA was reverse transcribed and used
to create indirectly labeled Cy5 cDNA as starting material for each
microarray.
Bovine Reference RNA
Bovine reference RNA was prepared in-house and constituted of
equal proportions of total RNA from Madin-Darby bovine kidney
and bovine B lymphocyte cell lines, and fresh bovine brain cortex
and cerebellum [24,25]. This reference RNA has been shown to
hybridize to the great majority of the open reading frames (ORFs)
represented on the microarray. The reference RNA was treated in
the same way as the experimental and control RNA for the co-
hybridization with each sample on the microarray.
Bovine Microarrays, Sample Preparation and
Hybridization
Bovine microarrays were obtained from the W. M. Keck Center
(University of Illinois at Urbana-Champaign). These custom
microarrays consisted of 70-mer oligonucleotides representing
13,258 unique oligos with 12,220 cattle ORFs. A detailed
description of the design and development of microarray has
been published elsewhere [26]. Labeling of cDNA and hybridiza-
tion to microarray have been described previously [27]. Briefly,
10 mg of RNA was reverse transcribed using Superscript III
reverse transcriptase (Invitrogen, Carlsbad, CA) and labeled with
amino-allyl-UTP (Ambion, Austin, TX). Cy3 and Cy5 dye esters
were covalently linked to the amino-allyl group by incubating the
samples with the dye esters in 0.1 M sodium carbonate buffer.
cDNA from bovine experimental samples (i.e. from MAP infected
and PBS control loops) were labeled with Cy5 and co-hybridized
against Cy3 labeled cDNA generated from the bovine reference
RNA sample 13K bovine 70-mer oligonucleotides array. Prior to
hybridization, the microarrays were denatured by exposing to
steam from boiling water for three seconds, cross-linked ultraviolet
light and then immersed in pre-hybridization buffer (56 sodium
chloride, sodium citrate buffer (SSC), 0.1% sodium dodecyl sulfate
(SDS) (Ambion, Austin, TX), 1% bovine serum albumin (BSA) at
42uC for a minimum of 45 min followed by four washes in RNase-
, DNase-free, distilled water, immersion in 100% isopropanol for
10 seconds, and dried by centrifugation. Slides were hybridized at
42uC for approximately 40 hrs in a dark humid chamber
(Corning, Corning, NY) and washed for 10 min at 42uC with
low stringency buffer (16SSC, 0.2% SDS), followed by two 5 min
washes in a higher stringency buffer (0.16SSC, 0.2% SDS and
0.16SSC) at room temperature in the dark with mild agitation.
Data Acquisition and Normalization of Hybridized Spots
on Microarrays
Slides were scanned using a GenePix 4100 laser scanner (Axon
Instruments Inc., Foster City, CA). The spots with fluorescent
signal representing genes on the arrays were adjusted for
background and normalized to internal controls using image
analysis software. If the fluorescent signal of any spot was below
the background, they were disregarded in all analyses. An average
of 56% of spots in experimental samples (Cy5 channel; laser
excitation= 635), 77% of spots in reference samples (Cy3 channel;
laser excitation = 532), and 54% of spots in the combined samples
(Cy5/Cy3 channels) had a signal to noise ratio greater than three.
Microarray Data Analysis
Microarray data analysis was performed by two different
methods. In the first method, arrays were normalized by scaling
against the average reference intensity value (i.e., average across all
microarrays), normalized by the global mean, and then log
transformed before statistical analyses were performed. Signals
flagged as ‘‘non-acceptable’’ by GenePix (Axon Instruments Inc.
Foster City, CA) were removed across all arrays in order to ensure
that subsequent analyses for each time point were comparable.
Pairwise comparisons of averaged signal values and Student’s t test
were performed using GeneSifter software (VizX Labs, Seattle,
WA). Normalization of each sample was performed against the
bovine reference RNA signals across slides and within each slide
(across the duplicate spots). Before normalization, duplicate spots
were separated and treated as technical replicates. The two spots
representing a single gene were therefore required to ‘‘agree,’’ based
on subsequent analysis steps. A fold-change of at least 1.5-fold and
P,0.05 was expected for a difference in signal to be considered
statistically significant. All possible individual pairwise comparisons
between controls and infections were also performed using Spotfire
DecisionSite software (Spotfire, Inc., Somerville, MA). Genes were
further filtered using these various comparisons in order to ensure
biological relevance (i.e., that observed differences were not the
result of random variation between uninfected animals) and
consistency (i.e., reproducibility across experiments).
In the second method, more recent computational tools termed
the BioSignature Discovery System (BioSignatureDS) (Seralogix,
LLC, Austin, TX) were employed to conduct comparative
pathogenicity analysis and modeling. This approach for genomic
data analysis and modeling at the system biology level offers an
integrated view of biological mechanisms and networks of
interactions. Specifically for the analysis reported herein, the tools
were used to: 1) determine significant gene modulations via a z-
score sliding window threshold technique and fold change; 2)
conduct biological system level analysis employing Bayesian
network models for scoring and ranking of metabolic pathways,
signaling pathways and gene ontology (GO) groups; 3) conduct
Bayesian candidate mechanistic gene analysis to identify genes
within the network models that are most responsible for causing
pathway and GO group perturbations; and 4) create a genetic
network system model derived from the candidate mechanistic
genes and their genetic interactions. More detailed description of
the computational techniques employed by BioSignatureDS was
described in our previous publication [24].
Microarray Data Deposited in the Gene Expression
Omnibus
The microarray data were deposited in the Gene Expression
Omnibus at the National Center for Biotechnology Information
(http://www.ncbi.nlm.nih.gov/geo/) Accession # GSE13888.
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Induction of RNAi in HeLa Cells
HeLa cells (ATCC CCL-2.2, from ATCC, Manassas, VA) were
cultured in F12K medium supplemented with L-glutamine and
10% heat inactivated fetal bovine serum (HI-FBS). On day 1,
approximately 46104 HeLa cells were placed into 24 well cell
culture Plates (Corning, Corning, NY) in 0.4 ml of culture
medium and placed in a 37uC incubator with 5% CO2. The
following day, for each 24-well culture to be transfected, 50 ml of
serum-free cell growth medium (OPTI-MEM, Invitrogen, Carls-
bad, CA) was mixed in separate compartments with SilencerH
validated siRNAs (Ambion, Austin, TX). The siRNAs were used at
final concentrations according to the manufacturer’s protocol:
mitogen-activated protein kinase 1 (MAPK1) (ID 1449) 30 nM,
MAPK1 (ID 1544) 100 nM, epidermal growth factor EGF (ID
645) 50 nM, and negative control siRNA (AM4635) 50 nM.
Simultaneously, 1 ml of TransFectinH lipid reagent (Bio-Rad,
Hercules, CA) was diluted into 50 ml of serum-free cell growth
medium for each 24-well culture to be transfected. The diluted
siRNA was combined and mixed with the diluted TransFectinH
reagent. Additional negative controls consisted of cells to which
either 100 ml of OPTI-MEM or 100 ml of OPTI-MEM with 1 ml
of TransFectinH were added. After 20 min incubation at RT,
100 ml of the siRNA-TransFectin mixture were added to the
400 ml of F12K cell culture media on the cells. On day 3, one ml of
F12K medium with 10% FBS was added to the each well. On day
4, transfected cells were infected with MAP at a multiplicity of
infection (MOI) of 10 bacteria per HeLa cell, and bacterial
invasion was determined as described below. For validation of
RNAi efficiency, RNA from transfected cells was extracted at the
same time of infection (i.e. 48 hrs post-transfection) using Tri
Reagent (MRC, Cincinnati, OH) according to the manufacturer’s
protocol. Contaminant genomic DNA was removed by RNase-
free DNase I treatment (Ambion) according to the manufacturer’s
instructions, and samples were stored at 280uC until used. RNA
concentration was quantitated by NanoDropH ND-1000 (Nano-
Drop, Wilmington, DW). Target mRNA levels were measured by
qRT-PCR as previously described for microarray validation [24].
Functional Assessment of siRNA Transfected HeLa Cells
For Invasion of MAP
HeLa cells were cultured as described above. Before adding
MAP, the HeLa cells from 2 wells were detached and counted.
Invasion assays were performed by removing 1.2 ml of the
medium overlying the HeLa cells monolayers and adding 100 ml
of a bacterial inoculum re-suspended in cell culture media, at a
MOI of 10:1. Bacteria were centrifuged onto the cells at 8006g for
2 min followed by 1 hr of incubation at 37uC. Then, cells were
washed three times with PBS to remove extracellular bacteria and
re-incubated with F12K media supplemented with 100 mg ml21 of
gentamicin solution (Sigma, St. Louis, MO) for 2 hrs. After
antibiotic treatment, infected cultures were washed three times
with PBS and then lysed with 0.1% Triton X-100 (Sigma). Lysates
were serially diluted and cultured on Herrold egg yolk media
supplemented with Mycobactin J and amphotericin, nalidixic acid,
and vancomycin for quantification of colony-forming units (CFU).
Duplicate wells were used for each experiment, and the
experiments were performed three times.
Kinetics of Trans-Epithelial Resistance of Polarized
Epithelial Cells During Invasion of pathogen
T84 cells (ATCC 14028, from ATCC, Manassas, VA) were
grown in DMEM/F12 medium (Gibco, Life Technologies)
containing 1.2 g of sodium bicarbonate per liter, 2.5 mM L-
glutamine, 15 mM HEPES, and 0.5 mM sodium pyruvate (Gibco,
Life Technologies) supplemented with 10% fetal calf serum. T84
cells were polarized by seeding 46105cells/well on the apical
compartment of 12-mm-diameter Transwell plates (polycarbonate
membrane with a pore size of 0.4 mm; Corning Costar) and 1.5 ml
of media was added to the basolateral compartment. The medium
was changed every other day, and the transepithelial electrical
resistance (TER) was measured after 7–8 days. After the cells
reached a TER of at least1,500 m/cm2, they were incubated
overnight in fresh medium, and the invasion assay was performed
on the following day using a MOI of 10:1. The change in the TER
was measured at various time intervals, starting at 2 mins post-
infection to 24 hrs post-infection, with a voltmeter (Millipore-ERS
resistance meter; Millipore, Bedford, Mass.).
Statistical Analysis of Bacteriology
Colonization of tissue samples and transfected HeLa cells was
considered to be positive when MAP was detected by bacterio-
logical culture. Tissue burden was defined as the number of colony
forming units per milligram of tissue. The statistical significance of
differences was calculated using two-tailed Student’s t test.
Table 1. Classical Analysis of Microarray by GeneSifter
Software.
Classical Analysis by GeneSifter MAP vs PBS
Upregu-
lated
Down-
regulated Total
30 Min
Average Fold Change $1.5-fold 519 2,468 2,987
Statistically significant (p value#0.05) 9 202 211
Biologically relevant and consistent 0 25 25
60 min
Average Fold Change $1.5-fold 644 2,185 2,829
Statistically significant (p value#0.05) 74 183 257
Biologically relevant and consistent 1 49 50
120 min
Average Fold Change $1.5-fold 888 1,987 2,875
Statistically significant (p value#0.05) 99 168 267
Biologically relevant and consistent 15 32 47
240 min
Average Fold Change $1.5-fold 688 1,585 2,273
Statistically significant (p value#0.05) 16 199 215
Biologically relevant and consistent 2 42 44
480 min
Average Fold Change $1.5-fold 1,745 727 2,472
Statistically significant (p value#0.05) 215 35 250
Biologically relevant and consistent 27 5 32
720 min
Average Fold Change $1.5-fold 2,030 2,278 4,308
Statistically significant (p value#0.05) 83 35 118
Biologically relevant and consistent 7 6 13
doi:10.1371/journal.pone.0042127.t001
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Table 4. Late Phase Significantly Perturbed Pathways Bayesian z-Scores.
Activated Pathway Description t =720 Activated Pathway Description (con’t) t = 720 Suppressed Pathway Description t = 720
Fructose and mannose metabolism 3.54 Type I diabetes mellitus 2.74 *ABC transporters 22.25
Cytokine-cytokine receptor interaction 3.4 DNA polymerase 2.73 *B cell receptor signaling pathway 22.25
Complement and coagulation cascades 3.37 *N-Glycan biosynthesis 2.73 *Non-small cell lung cancer 22.25
Hedgehog signaling pathway 3.3 RNA polymerase 2.73 *Chronic myeloid leukemia 22.26
*Biosynthesis of steroids 3.29 Gap junction 2.72 *Melanoma 22.28
Riboflavin metabolism 3.26 *Type II diabetes mellitus 2.72 *Renal cell carcinoma 22.28
*Circadian rhythm 3.24 Inositol metabolism 2.71 *Biotin metabolism 22.29
Starch and sucrose metabolism 3.23 *mTOR signaling pathway 2.7 *Terpenoid biosynthesis 22.29
*Alzheimer’s disease 3.22 PPAR signaling pathway 2.66 *VEGF signaling pathway 22.31
Melanogenesis 3.21 ErbB signaling pathway 2.64 *Valine, leucine and isoleucine
biosynthesis
22.32
One carbon pool by folate 3.21 *Taste transduction 2.64 *Linoleic acid metabolism 22.37
Wnt signaling pathway 3.15 Tyrosine metabolism 2.64 *Aminoacyl-tRNA biosynthesis 22.39
TGF-beta signaling pathway 3.08 *Sphingolipid metabolism 2.63 *Glioma 22.4
Basal cell carcinoma 3.07 *Cell adhesion molecules (CAMs) 2.56 Small cell lung cancer 22.42
*Aminosugars metabolism 3.06 Phenylalanine metabolism 2.55 *Colorectal cancer 22.43
Cell Communication 3.06 *Epithelial cell signaling Helicobacter pylori
infection
2.53 Proteasome 22.45
Long-term potentiation 3.06 *Phenylalanine, tyrosine & tryptophan
biosynthesis
2.52 Propanoate metabolism 22.5
CD40L Signaling Pathway 3.03 *Cholera 2.51 Lysine degradation 22.51
Hematopoietic cell lineage 3.03 *Glutamate metabolism 2.51 Porphyrin and chlorophyll metabolism 22.61
Pyruvate metabolism 3.03 Alkaloid biosynthesis I 2.49 Carbon fixation 22.62
ECM-receptor interaction 3.02 Pathogenic Escherichia coli infection 2.49 Citrate cycle (TCA cycle) 22.63
Olfactory transduction 3.01 Acute myeloid leukemia 2.48 Axon guidance 22.64
Neuroactive ligand-receptor interaction 2.99 Stilbene, coumarine and lignin biosynthesis 2.48 *gamma-Hexachlorocyclohexane
degradation
22.64
Glycan structures - biosynthesis 1 2.98 Reductive carboxylate cycle (CO2 fixation) 2.47 *Leukocyte transendothelial migration 22.7
Chondroitin sulfate biosynthesis 2.96 Alanine and aspartate metabolism 2.44 *D-Glutamine and D-glutamate
metabolism
22.73
Folate biosynthesis 2.96 GnRH signaling pathway 2.42 Cytokine Inflammatory Response 22.77
Pentose and glucuronate interconversions 2.93 *Pyrimidine metabolism 2.41 *Cell cycle 22.81
*Galactose metabolism 2.92 Parkinson’s disease 2.39 Tetrachloroethene degradation 22.82
Jak-STAT signaling pathway 2.91 Methionine metabolism 2.37 Oxidative phosphorylation 22.88
Arachidonic acid metabolism 2.9 Bile acid biosynthesis 2.36 microtubule-associated protein 1A 23.3
*Protein export 2.89 Peptidoglycan biosynthesis 2.36 *Thiamine metabolism 23.3
Endometrial cancer 2.86 *Valine, leucine and isoleucine degradation 2.36
Regulation of actin cytoskeleton 2.86 Glycosylphosphatidylinositol(GPI)-anchor
biosynthesis
2.35
Toll-like receptor signaling pathway 2.85 *MAPK signaling pathway 2.35
Butanoate metabolism 2.84 *Prostate cancer 2.35
C5-Branched dibasic acid metabolism 2.84 *Bladder cancer 2.33
Glycine, serine and threonine metabolism 2.84 Inositol phosphate metabolism 2.33
Adipocytokine signaling pathway 2.83 *Novobiocin biosynthesis 2.33
Glycolysis/Gluconeogenesis 2.82 *Monoterpenoid biosynthesis 2.32
*Glycerolipid metabolism 2.8 *Apoptosis 2.3
Calcium signaling pathway 2.78 Thyroid cancer 2.29
Purine metabolism 2.77 Regulation of autophagy 2.28
Synthesis and degradation of ketone bodies 2.76 Arginine and proline metabolism 2.26
doi:10.1371/journal.pone.0042127.t004
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Results
Invasion of Ileal Mucosa by MAP
MAP was recovered from the MAP-inoculated ileal tissues at all
the time points post-infection (data not shown). No bacteria were
detected in the PBS inoculated loops. Among the infected loops,
no significant changes in the number of MAP were detected at any
times post-inoculation (0.5–12 hrs).
Bovine Peyer’s Patches Inoculated with MAP Reveals a
Complex Temporal Pattern of Transcriptional Profile
In order to gain detailed insight into the changes in the
transcriptional profile of genes in bovine intestinal Peyer’s patch
mucosa inoculated with 36109 cfu of MAP (30, 60, 120, 240, 480,
and 720 min post-infection), initially the microarray data analysis
was performed by using GeneSifter software (where a fold-change
Figure 1. Significantly Perturbed Pathways of the Early Phase Immune Response. The darker red gradients indicate higher activation
scores (more up-regulated gene expression within the pathway) while the darker green gradients indicate more suppressed pathway activity (more
down-regulated gene expression) of MAP infected Peyer’s patch. The pathway threshold score was selected for a 97.5% confidence.
doi:10.1371/journal.pone.0042127.g001
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of at least 1.5-fold and P,0.05 was required for a difference in
signal to be considered statistically significant, Table 1). Classical
analysis of the altered gene expression by GeneSifter, provides the
static changes in the experimental conditions with a profound
spectrum of data; however, after filtering the data into the
biological relevant and significant genes, a limited number of genes
were found to have statistically significant expression.
As shown in Table 1, no genes were significantly up-regulated in
MAP-infected animals at the earliest time point tested (30 min),
and only modest numbers of genes (less than 30 by 8 hr) were
increased in expression over the experimental time course. In
contrast, at the earliest time points, MAP-infected loops had down-
regulation in gene expression. This observation clearly reflected
that measurement of subtle changes may be undetected if: 1) the
quantity of the change is very small to measure, or 2) if
experiments are conducted using out bred populations, or 3) if
the sample used is a heterogeneous population of several cell types
expressing different levels of expression of same gene. To
overcome these challenges, we extended the analysis to create a
temporal relationship of various genes using BiosignatureDS tools
that employed a method termed the Dynamic Bayesian Gene
Group Activation (DBGGA)(Seralogix, Austin, TX). Bayesian
network models were created for all the known signaling and
metabolic pathways and for Gene Ontology (GO) biological
processes. The models were trained with the control group data
(uninfected) with the experimental data (infected) used as evidence
to test how different experimental data are applied in fitting the
control model. This difference is determined by measuring the
negative log-likelihood that, in turn, was transformed to a z-score
test statistics that is referred to, here after, as the Bayesian z-score.
This method ranked groups of genes at each time point and across
all time points to determine differences between experimental
conditions [24,28]. Similarly, how well the results of individual
genes fit a model was also determined, producing Bayesian z-
scores for each gene within a pathway or GO category. This
method used a less stringent spot quality filtering technique; a
more sophisticated universal reference normalization method in
conjunction with Lowess correction; and a Bayesian variance
estimator that infers a better prediction of the standard deviation
for genes which have a low number of biological replicates [29,30].
Using this approach, the contribution of small changes in key
regulatory genes was taken into account.
Classification of Perturbed Pathways using Bayesian z-
scoring Divides the Host Transcriptional Response into
Three Phases
As indicated by the host system level pathway analyses that
identified significantly perturbed pathways over the experimental
time course, there were three logical classification phases (Early,
Intermediate and Late) in which it is proposed that invasion occurs
in the Early Phase and longer term evasion and host immune
tolerance occurs in all three phases. The Early Phase of infection
consisted of the 30 and 60 min time periods post-infection. The
Intermediate Phase consisted of the 120, 240, and 480 min time
periods post-infection, and the Late Phase infection at 720 minutes
post-infection. A comprehensive Bayesian z-score list of signifi-
cantly perturbed pathways identified for MAP inoculated loop,
passing the 97.5% confidence threshold is provided in Tables 2, 3,
and 4, organized into Early, Intermediate, and Late Phase
responses, respectively. The rank order of pathways in Tables 2,
3 and 4 are based on the Bayesian z-scores ranging from largest to
smallest for the first time point in each of the phases (i.e.,
t = 30 minutes for Early, t = 120 minutes for Intermediate, and
t = 720 minutes for Late). These tables organize the pathways in
terms of their state of activation or suppression. Of 220 pathways
scored by the DBGGA method, the Early Phase response had 82
significantly perturbed signaling and metabolic pathways, the
Intermediate Phase had 70, and the Late Phase had 117. There
were 30 pathways that were significantly perturbed in common to
all three phases and are highlighted in italics in Tables 2, 3 and 4.
The Early Phase had 23 pathways that were uniquely perturbed
compared to the other phases while the Intermediate Phase had
only 11, and the Late Phase had 45 uniquely perturbed pathways.
These uniquely perturbed pathways are indicated in these tables
with an ‘‘*’’ before the name of the pathway. As a supplement to
Tables 2, 3 and 4, a heat map of all pathway scores is provided in
Figure S1 to better visualize the temporal patterns and the degree
of perturbation at each time point post infection.
System Level Pathway Results and Immune Response
Phases
There were 30 common pathways significantly perturbed in all
three phases. These common pathways may be important to both
short term and long term host tolerance to MAP. In the
‘‘common’’ pathways, there were several pathways involved in
the host immune response including: Complement and Coagula-
tion Cascades indicating a non-specific defense mechanism;
Hematopoietic Cell Lineage indicating immune cell differentia-
tion; CD40L Signaling indicating T cell activation; Cytokine-
Cytokine Receptor indicating immune cell communication, PPAR
Signaling indicating inflammatory response of immune cells; and
Toll-Like Receptor Signaling that signifies triggering the innate
immune response. These immune related pathways all had
basically strong activation as shown in Table 2 for the Early
Phase in Figure 1.
A few pathways that were apparently being manipulated by
MAP infection showed a reversal from suppression in the Early
Phase to activation in the Late Phase that include Cell
Communication, One Carbon Pool by Folate, and Long-term
Potentiation while the Microtubule-associated Protein 1 pathway
reversed from activated to a suppressed state (Figure 1). Other
pathways that were activated in all three phases include
Complement and Coagulation Cascade pathway, Adipocytokine
Signaling Pathway, Hematopoietic Cell Lineage Pathway, and
Neuroactive ligand-receptor interaction. The genes and networks
involved in these pathways are discussed in more detail in the
Discussion section.
There are 23 pathways that are uniquely perturbed during the
Early Phase of MAP infection and 26 non-unique pathways that
are in common with either the Intermediate or Late Phases that
include a number of immune and metabolic pathways as
annotated in Tables 2, 3 and 4. These included for example,
Tyrosine Metabolism, Histidine Metabolism, Phosphatidylinositol
Signaling System, Tryptophan Metabolism, Selenoamino Acid
Metabolism, Androgen and Estrogen Metabolism, Glycosphingo-
lipid Biosynthesis, Aminophosphonate Metabolism, Glyceropho-
spholipid Metabolism, GnRH Signaling Pathway, Ether Lipid
Metabolishm, and Glycolysis/Gluconeogenesis.
The temporal perturbation of these pathways illustrates the
complexity of MAP’s pathogenicity in the host. The functional
roles of these pathways with regard to host invasion and evasion
are presented in more detail In the Discussion section. The
analysis resulted in the development of a biological systems level
model.
Gene Ontology (GO) Biological Process Results
The DBGGA scoring method was applied to 2,254 GO
biological process categories. Each category had to contain at
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least 10 measured genes to be scored. For GO scoring, the
DBGGA method employs a naive Bayesian classifier network
model. Scoring results indicated that the Early Phase response had
467 significantly perturbed GO categories (Table S1), the
Intermediate Phase had 105 (Table S2), and the Late Phase had
691 (Table S3). There were 27 GO categories that were
significantly perturbed in common to all three phases. In the
Early Phase there were 272 uniquely perturbed GO categories
while the Intermediate Phase had 31 and the Late Phase had 459
that were uniquely perturbed. There is a broad range of strongly
activated and suppressed biological processes. Several GO
categories of interest were selected from the Early Phase for heat
map plotting shown in Figure 2. Of the top 50 GO activated
categories, early Phase activation may be associated with MAP
host invasion and early immune defense processes. In contrast, of
the top 50 suppressed GO categories, the suppressed categories
may be a result of MAP’s manipulation of these host’s processes to
facilitate invasion into the host cells and to subvert the host’s
immune defenses.
Several activated GO categories of interest include processes
involved in: 1) early to late endosome transport; 2) cellular calcium
ion homeostasis; 3) induction of apoptosis; 4) positive regulation of
NF-kB transcription factor activity; 5) inactivation of MAPK
activity; 6) vacuolar transport; 7) Wnt receptor signaling; 8) actin
filament bundle formation; 9) defense response to Gram-positive
bacterium; and 10) activation of phospholipase C activity. These
categories all had an activated state in the Early Phase of the
immune response (Figure 2). Interestingly, there were six GO
categories that reversed from activated state in the Early Phase to a
suppressed state in the Late Phase that included: 1) positive
regulation of vasodilation; 2) T-helper 1 type immune response; 3)
complement activation, alternative pathway; 4) regulation of Rab
GTPase activity; 5) response to toxin; and 6) activation of
transmembrane receptor protein tyrosine kinase activity.
Several interesting GO categories that were suppressed in the
Early Phase and then reversed to an active state in the Late Phase
include processes involved in: 1) I-kB kinase/NF-kB cascade; 2)
actin cytoskeleton reorganization; 3) Wnt receptor signaling
pathway through beta-catenin; 4) T cell differentiation; 5)
microtubule-based movement; 6) positive regulation of endocyto-
sis; 7) positive regulation of apoptosis; 8) cytoskeletal anchoring at
plasma membrane; 9) response to calcium ion; 10) negative
regulation of NF-kB transcription factor activity; and 11) negative
regulation of axon extension. Other categories that were
suppressed in the Early Phase and remained suppressed or neutral
included: 1) Rho protein signal transduction; 2) positive regulation
of Wnt receptor signaling pathway; 3) T cell proliferation; 4)
regulation of actin filament polymerization; 5) cell-cell junction
assembly; 6) post-Golgi vesicle-mediated transport; and 7)
regulation of lipoprotein lipase activity.
There were 554 GO categories that were strongly activated in
the Late Phase (Table S3). These activated categories provided
evidence of the host mounting a more effective immune response
that included: 1) neutrophil activation; 2) positive regulation of
inflammatory response; 3) innate immune response; 4) positive
regulation of B cell proliferation; 5) positive regulation of T cell
mediated immunity; 6) endothelial cell proliferation; 7) positive
regulation of cytokine production; and 8) positive regulation of cell
adhesion. In contrast, there were only 130 GO categories that
were significantly suppressed in the Late Phase that included: 1)
immunoglobulin mediated immune response; and 2) natural killer
cell activation.
Discovery of Mechanistic Genes during MAP Infection
Reveals Importance of the Cross-Talk via Inter-Pathway
Interactions
The DBGGA analysis identifies mechanistic genes by Bayesian
modeling of the genes in the context of their upstream and
downstream relationships over the complete time course. Mech-
anistic genes significantly influenced disease progression and
contributed most to the discrepancies between the MAP infected
vs. PBS control tissue. We propose that these mechanistic genes
may play an important role in the outcome of the host-pathogen
interaction. A complete list of all the mechanistic genes is provided
in the Table S4. We further focused on only 43 pathways involved
Figure 2. Top 50 Activated and Suppressed Perturbed Gene Ontology Scores Early Phase Response. The darker red gradients indicate
higher activation scores (more up-regulated gene expression within the pathway) while the darker green gradients indicate more suppressed GO
activity (more down-regulated gene expression) of MAP infected Peyer’s patch. The pathway threshold score was selected for a 97.5% confidence.
doi:10.1371/journal.pone.0042127.g002
Figure 3. Pathway Scores for Cell Communication and Cell
Adhesion Pathways and their Involvement in Trans-Epithelial
Resistance (TER). The set of genes within the gap junction, tight
junction, adherens junction and integrin-mediated cell adhesion are
contained in the cell communication pathway. (3a). Pathway scores for
Adherens Junction (AJ), Cell Communication (CC), Gap Junction (GJ),
Integrin-mediated Cell Adhesion (IMCA), Tight Junction (TJ) and Trefoil
Factors Initiated Mucosal Healing (TFIMH). Red indicates an activated
state while green indicates suppression. Note the reversal of the cell
communication pathway from suppressed to activated from the Phase
1 (30–60 min.) to the Phase 3 time period (720 min.). (3b). Changes in
the Trans-Epithelial Resistance of polarized T-84 cells exposed to MAP
for 24 h. Data represent mean 6 SD from 3 measurements at each time
point and three independent experiments.
doi:10.1371/journal.pone.0042127.g003
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in signaling and immune response. Our intent was to identify
mechanistic genes that are associated in multiple pathways which
may be the source of cross-talk and thus have more significant
influence governing the host immune tolerance to MAP and
illustrating the importance of cross-talk. Of the 43 pathways
analyzed, 36 pathways had at least one overlapping mechanistic
gene. It was found that 141 mechanistic genes had overlaps within
the 36 pathways examined. These genes are listed in Table S5. Of
highest interest were those genes that had influence (overlap)
across numerous pathways. The mechanistic gene, AKT2 (v-akt
murine thymoma viral oncogene homolog 2), had overlap with 11
important pathways that include: 1) Adipocytokine signaling; 2)
Insulin signaling; 3) Fc epsilon RI signaling; 4) T cell receptor
signaling; 5) Toll-like receptor signaling; 6) Tight junction; 7)
Integrin-mediated cell adhesion; 8) VEGF signaling; 9) mTOR
signaling; 10) ErbB signaling; and 11) MAPK signaling. These
pathways are involved in a wide variety of biological processes
including, but not limited to cell proliferation, differentiation,
apoptosis, tumorogenesis, as well as glycogen synthesis and glucose
uptake. The protein encoded by AKT2 is a member of the AKT,
also called PKB, serine/threonine protein kinase family. AKT
kinases play a key role in regulating cell survival, insulin signaling,
angiogenesis and tumor formation. Only 14 other mechanistic
genes had overlap with 6 or more pathways as listed in Table S5.
Several cytokines (IL1a, IL1ß, IL4R, IL5, IL7, IL15, IL23A, IFN-c)
were also overlapping mechanistic genes in analyzed pathways.
These genes will be addressed in more detail in the Discussion
section.
Discussion
MAP has the uncanny ability to persist within the host for an
indefinite period of time that can last several years. Hence, MAP
must have efficient host invasion and host immune evasion
processes that should be evident by MAP’s manipulation of certain
host immune response and metabolic pathways. We utilized the
perinatal calf ligated jejunal-ileal loop model to study the
sequential changes in the host intestine immediately after infection
with MAP. A key role of intestinal mucosal epithelia is barrier
function, which prevents colonization or invasion by foreign
microorganisms. However, in Johne’s disease, MAP invade M
cells, enterocytes, dendritic cells and macrophages, and are
capable of resisting host defenses and multiply to reach very high
intracellular numbers leading to chronic granulomatous lesions
[31,32]. In infected subclinical and clinically affected animals,
systemic immune response is achieved. Persistence of the organism
in the intestinal Peyer’s patch in the presence of a systemic
immune response suggests that the immune response in the
intestine may be fundamentally different from the systemic
response. In fact, a state of immune tolerance was detected at
the mucosal level during subclinical Johne’s disease [7]. Further-
more, it has been shown earlier that the human intestinal
macrophages display profound inflammatory anergy despite avid
phagocytic and bacteriological activity [33]. The aim of our study
was to discover if the immune tolerance is initiated, and if so, how
quickly after the pathogen comes in contact with the intestinal
mucosa. We hypothesized from a biological system perspective
that MAP pathogenicity should show evidence of: 1) host invasion
by manipulating host cellular functions related to mucosal immune
barrier; and 2) subversion of host immune response that permits
MAP uptake, survival and proliferation.
Host Invasion through Compromising the Mucosal
Immune Barrier
In the pathway scores listed in Tables 2, 3 and 4, there are
several suppressed pathways that may be associated with MAP
host invasion by impeding mucosal epithelial barrier function that
include Cell Communication (CC), Tight Junction (TJ), Integrin-
mediated Cell Adhesion (IMCA), and Trefoil Factors Initiated
Mucosal Healing (TFIMH) pathways. A key observation is the
suppressed state of the Cell Communication Pathway, which
interestingly was suppressed in the Early Phase and became
activated in the Late Phase (Figure 1). The CC pathway includes
the genes from the TJ, IMCA as well as the Gap Junction (GJ) and
Adherens Junction (AJ) pathways. These pathways form the
intercellular junction complexes between adjacent intestinal
epithelial cells that are critical components of the intestinal
mucosal barrier that creates a semi-permeable diffusion barrier.
Studies have shown that activation (increased gene expressions) of
these junction pathways may lead to strengthening the intestinal
barrier while suppression (disrupted gene expression) may result in
weakening of the immune barrier. As shown in the heat map
scores of Figure 3(a), the AJ, TJ, and TFIMH pathways are
suppressed in the Early Phase while the state of the Gap Junction
pathway was activated. This suggests that MAP host invasion may
be disrupting critical cell communication processes in a complex
manner. This complex nature of cell disruption was also analyzed
by measuring the Trans-Epithelial Resistance (TER) of an in vitro
model polarized epithelial cells during MAP interaction
(Figure 3(b)). MAP infection caused a marked decrease in the
TER, adding credibility that increased permeability of in vivo host
intestinal epithelium may facilitate bacterial invasion through the
intestinal epithelium.
Cell adhesion serves to facilitate trafficking and migration of T
lymphocytes into sites of inflammation, movement of lymphocytes
within the rich environment found in extravascular tissue, and the
physical interaction between antigen-reactive T cells and antigen-
presenting cells that is required for efficient T-cell activation [34].
As shown in Figure 3(a), the IMCA and TFIMH pathways are
suppressed in the early and Late Phases which suggest that MAP
may disrupt T lymphocyte recruitment that helps explain the lack
of chronic inflammation observed in the MAP infected ileal loops
and subvert mucosal healing. Over time the trend is for the TJ,
IMCA and TFIMH pathways to remain suppressed, but GJ and
AJ pathways become activated. This suggests that MAP may need
to suppress important host cell communication, adhesion and
healing processes for penetrating the mucosal immune barrier, but
activate cell adhesion mechanisms for longer term survival in the
Late Phase. It has been proposed by others [35] that some bacteria
survival mechanism in mucosal epithelial cells is for the bacteria to
hijack integrin-linked kinase to stabilize focal adhesions and block
cell detachment of infected cells. The rapid turnover and
exfoliation of mucosal epithelial cells provides an innate defense
system against bacterial infection. Nevertheless, bacteria such as
MAP may be able to subvert this immune defense mechanism and
colonize the epithelium efficiently and survive. Furthermore, M
cells are unique among cells of the intestinal epithelium as they
display a high density of Beta1 integrins on their luminal surface.
In a recent study, we documented that the early host response was
evident by the presence of MAP in the vicinity of M cells and
goblet cells [2]. Integrins have affinity for the fibronectin
attachment protein of MAP. Thus, M cells are thought to play a
role in the host defense by down-regulating integrins and thus
avoiding the fibronectin bridge formation for the entry of MAP
into the ileal mucosa [36].
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Junction (Gap, Tight, Adherens) Pathways. The junction
related mechanistic genes (significant differential gene expressions
determined by DBGGA analysis) are shown in the heat map of
Figure 4. The key down-regulated genes of high interest in the
Early Phase include: MAPK1, CTNNB1, ERBB2, PARD3 ACTN2,
CLDN7, ACTB, CSNK2B, CSNK2B, GNAI3, MAP2K1, TCF7L1,
SRC and whose biological roles are described in Table 5. Many of
these genes are involved with maintaining the integrity of the
epithelial layer. According to the Adherens Junction Bayesian
network model (not shown), SRC has strong correlated relation-
ships with other downstream genes, i.e., the gene relationship
SRC-.RAC1. RAC1 (ras-related C3 botulinum toxin substrate 1
rho family small GTP binding protein Rac1) gene expression is
suppressed across all three phases. RAC1 encodes a GTPase
protein belonging to the RAS superfamily of small GTP-binding
proteins that regulate a diverse array of cellular events including
the control of cell growth, cytoskeletal reorganization, and the
activation of protein kinases.
Cell Adhesion Molecules (CAM) and Integrin-Mediated
Cell Adhesion (IMCA) Pathway. The impairment of cell
adhesion may be an important mechanism for MAP invasion in
the Early Phase as evident by the IMCA pathway suppression,
while the strong Late Phase activation of CAM pathway may be a
MAP survival mechanism which prevents infected cell detach-
ment. To explore this in more detail, the gene level activities in the
Early, Intermediate, and Late Phases were examined (Figure 5).
An important gene, CDH5 (cadherin 1, type 1, E-cadherin
(epithelial)), of epithelial cells that form an adhesion point for
Figure 4. Heat Map of Mechanistic Genes for Junction (Adherens, Gap, and Tight) Related Pathways. The junction related
mechanistic genes determined significant by DBGGA analysis. The heat map shows a dominance of down regulated junction related gene
expression occurring in the Early Phase as indicated by the darker green boxes. Genes listed surpassed the |Bayesian z-score|.2.24 at any of the time
points. Red indicates up regulation while green indicates down regulation. Time is minutes post-infection.
doi:10.1371/journal.pone.0042127.g004
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many subtypes of lymphocytes including intraepithelial lympho-
cytes lacked expression or was slightly down-regulated in all
phases. Integrins function in neutrophil adherence but the majority
of integrins was down regulated or not expressed in the Early
Phase. The Intermediate and Late Phases had a greater number of
up regulated integrins that may support the strengthening of the
immune barrier. In the CAM and IMCA pathway there were nine
strongly down-regulated genes in the Early Phase that supports
impaired cell adhesion, i.e. mucosal barrier weakening. These
genes include ITGB1, PTK2, MAP2K1, SELL, MAPK1, Mpzl1,
CD99, ITGA4 and CLDN7 and are described in Table 6. Note that
CLDN7 was described above as an integral membrane protein and
component of tight junction as was the role of MAPK1. The key
Intermediate and Late Phase up-regulated genes in the CAM and
IMCA pathways, in support of MAP survival mechanism (mucosal
barrier strengthening) are PDPK1, CNTN1, NRXN3, SPN, CSPG2,
HLA-DOB, SELP, PTPRC, ITGAM, TLN1, NCAM1, and RHOC.
Detailed description of these genes is provided in Table 7.
Trefoil Factors Initiated Mucosal Healing (TFIMH)
Pathway. Epithelial continuity can also depend on a family of
small, yet abundant, secreted proteins–the trefoil factors. The
immune related TFIMH pathway is suppressed in the Early Phase
(Figure 3a). The trefoil factors maintain the integrity of the
gastrointestinal tract, despite the continual presence of microbial
Table 5. Junction (Gap, Tight, Adherens) Pathways Mechanistic Genes.
MAPK1 mitogen-activated protein kinase 1 a gene encoding a member of the MAP kinase family known
as extracellular signal-regulated kinases (ERKs) which act as an
integration point for multiple biochemical signals, and are
involved in a wide variety of cellular processes such as
proliferation, differentiation, transcription regulation, and
development
2) CTNNB1 catenin beta 1 a gene encoding a protein necessary for the creation and
maintenance of epithelial cell layers by regulating cell growth
and adhesion between cells and also anchors the actin
cytoskeleton
ERBB2 v-erb-b2 erythroblastic leukemia viral oncogene homolog 2 encodes a member of the epidermal growth factor (EGF)
receptor family of receptor tyrosine kinases;
PARD3 par-3 partitioning defective 3 homolog gene encodes an adapter protein involved in asymmetrical
cell division and cell polarization processes and plays a central
role in the formation of epithelial tight junctions
ACTN2 actinin, alpha 2 encodes a cytoskeletal protein that anchors actin to a variety
of intracellular structures
CLDN7 claudin 7 encodes a member of the claudin family which includes
integral membrane proteins and components of tight
junction strands that serve as a physical barrier to prevent
solutes and water from passing freely through the paracellular
space between epithelial or endothelial cell sheets and also
play critical roles in maintaining cell polarity and signal
transductions
ACTB actin, beta encodes an actin protein involved in cell motility Structure
and integrity and is a major constituent of the contractile
apparatus
CSNK2B casein kinase 2 gene encodes a beta subunit of casein kinanse II, a serine/
threonine protein kinase that is thought to have a regulatory
function in cell proliferation, cell differentiation, and apoptosis
and also thought to influence Wnt Signaling via beta-catenin
phosphorylation and the PI 3-K signaling pathway via the
phosphorylation of Akt
GNAI3 guanine nucleotide binding protein (G protein) gene encodes a protein that is a membrane bound GTPase
that is linked to 7-TM receptors
MAP2K1 mitogen-activated protein kinase kinase 1 gene encodes a protein that is a member of the dual
specificity protein kinase family which acts as a mitogen-
activated protein (MAP) kinase kinase and is an integration
point for multiple biochemical signals
TCF7L1 transcription factor 7-like (T-cell specific HMG-box) a transcription factor activated by beta catenin and known to
mediate the Wnt Signaling pathway
SRC v-src sarcoma viral oncogene encodes the tyrosine-protein kinase protein that plays a role
in cell growth. According to the Adherens Junction Bayesian
network model the gene relationship SRC-.RAC1. RAC1 gene
expression was suppressed across all three phases. RAC1 (ras-
related C3 botulinum toxin substrate 1 rho family small GTP
binding protein Rac1) encodes a GTPase protein belonging to
the RAS superfamily of small GTP-binding proteins that
regulate a diverse array of cellular events including the
control of cell growth cytoskeletal reorganization and the
activation of protein kinases
doi:10.1371/journal.pone.0042127.t005
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flora and injurious agents [37]. Unfortunately, the trefoil factors
gene probes were not included on the bovine microarray
employed during this study. However, the TFIMH pathway
suppression (as determined by other observed gene expressions)
could imply impaired trefoil factors gene expression, and
consequently, a possible invasion mechanism of MAP by
subverting mucosal healing. Genes that dominate the suppressed
pathway activity are PTK2, ITGB1, MAPK1 and CTNNB1. The
biological roles of these genes are described in Table 8.
Subversion of Host Immune Response Processes
Host Cellular Uptake of MAP and Phagocytosis
Arrest. A new perspective in the pathogenesis on mycobacterial
diseases (M. tuberculosis) is the exploitation of host cell signaling
pathways by the pathogen. Upon infection, the phosphatases and
kinases of several pathogenic bacteria modify host proteins and
help in the establishment of the disease. The uptake of M.
tuberculosis by macrophages is associated with a number of Early
Phase signaling events, such as the recruitment and activation of
members of the Src family of protein tyrosine kinases [38]. These
kinases result in the increased tyrosine phosphorylation of multiple
macrophage proteins and the activation of phospholipase D [39].
Phospholipase products have been linked to phagocytosis mech-
anisms of bacteria uptake [40]. Examination of the pathways that
include CSK (c-src tyrosine kinase) indicated that this gene is
significantly up-regulated in the Early Phase and transitioned to a
moderately down-regulated state in the Intermediate and Late
Phases. CSK is associated with the Regulation of Actin Cytoskel-
eton, Epithelial Cell Signaling, Integrin-mediated Cell Adhesion,
and Activation of Csk Through T-Cell Receptor pathways, all of
these pathways were highly activated in the Early Phase and
transitioned to suppressed states in the Intermediate and Late
Phases. In this study, several classes of phospholipases were
significantly up-regulated in the Early Phase that included
PLA2G1B (phospholipase A2, group IB (pancreas)), PLCD1
(phosholipase C, delta 1), PLCB4 (phospholipase C, beta 4), and
PLD1 (phospholipase D1, phosphatidylcholine-specific). Table 9
lists the pathways in which these genes are considered mechanistic.
Phospholipases are a group of enzymes that hydrolyze phospho-
lipids into fatty acids and other lipophilic molecules and have been
implicated in numerous cellular pathways, including signal
transduction, membrane trafficking, and the regulation of mitosis.
Elevated levels of phospholipases have been linked to intracellular
calcium elevations during bacteria invasion [41].
It has been shown that M. tuberculosis is able to hi-jack lipid
metabolism to drive the progression of the disease [39,42,43]. The
Phosphatidylinosital Signaling System (PSS) is of interest, because
phosphatidylinositol lipids have been identified as key signaling
mediators for random cell migration as well as chemoattractant-
induced directional migration. The PSS was initially highly
activated and trended to be suppressed in the Late Phase.
Phosphatidylinosital Signaling System (PSS)
Pathway. The significantly up-regulated genes involved in this
signaling event were PLCD1, PLCB4, INPP4A, ITPR2, ITPR3. The
genes, PLCD1 and PLCB4 genes encode phospholipases that are
ubiquitously expressed and have diverse biological functions
including roles in inflammation, cell growth, signaling and death
and maintenance of membrane phospholipids. Significantly down-
regulated in all immune response phases in PSS is the gene
CALM2 (calmodulin 2) that is known to mediate the control of a
large number of enzymes and other proteins by Ca++. The
biological roles of these genes are described in Table 10.
It has been observed elsewhere [44] that pathogenic mycobac-
teria (human macrophages infected with Mycobacterium avium subsp.
hominissuis) have been shown to interfere with Ca++ and PI3K
signaling pathways which are essential pathways for phagosomal
maturation that requires CALM2 activation. The CALM2 gene
expression data, from the referenced human macrophage study,
was consistently down-regulated at all measured time points along
with markedly reduced STX3 (syntaxin 3) expression.
Microtubule-Associated Protein 1 (M-AP1)
Pathway. Syntaxins are included in the M-AP1 pathway that
was highly activated in the Early Phase. The protein encoded by
STX3 is a member of the syntaxin family of cellular receptors for
transport vesicles that participate in exocytosis in neutrophils.
Other members of the syntaxin family have been associated with
M. tuberculosis phagosome maturation arrest [45]. This pathway
reversed from a highly activated state to a highly suppressed state
in Late Phase (Figure 1). It has been observed in murine
Figure 5. Cell Adhesion Related Gene Scores. The heat map
shows a dominance of higher perturbed cell adhesion gene expression
(both up- and down-regulated) occurring in the Early Phase as indicated
by the darker red and green boxes for time t = 30 and t = 60 minutes.
Genes listed surpassed the |Bayesian z-score|.2.24 at any of the time
points. Red indicates an activated state while green indicates
suppression. Time is minutes post-infection.
doi:10.1371/journal.pone.0042127.g005
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macrophages that mycobacteria arrest the maturation of the early
endosome to a phagolysosome by inhibiting fusion of the
mycobacterium-containing phagosome with lysosomes [46–48].
The M-AP1 pathway activation reversal may suggest an important
mechanism for MAP host immune evasion. In the M-AP1
pathway genes, SNAP23 and Vamp2, were highly up-regulated,
while the genes, Vti1a and YKT6, were strongly down-regulated in
the Early Phase. In the Late Phase, there were five strongly down-
regulated genes that dominate the suppression of M-AP1 pathway.
These down-regulated mechanistic genes include Vti1b, STX8,
STX10, YKT6, STX6 and GOSR2. The STX genes are members of
the syntaxin family involved in protein trafficking from early to
late endosomes via vesicle fusion and exocytosis. The biological
roles of these genes are described in Table 11.
Calcium Signaling (CS) Pathway. The CS pathway was
strongly activated in all three phases suggesting MAP infection has
influence on this process during invasion and possibly related to
MAP survival long term. Calcium signaling plays an important
role in a broad range of regulatory effects on enzymes and proteins
and influence on other major pathways including MAPK
Signaling, Apoptosis, Long-term Potentiation, Long-term Depres-
sion, Phosphatidylinositol Signaling and others. Across all three
immune phases, there were three significantly up-regulated genes
that include NFATC4, CAMK2A, and PLCB3 while there were
another four genes that are significantly up-regulated only in the
Early Phase that include ADCY8, EDNRB, NFKBIB, and TACR2.
There were four significantly down-regulated genes that included
CALM2, PPID, GNAQ, and ATP2B4. The biological roles of these
genes are described in Table 12. NFATC4 plays a role in the
inducible expression of cytokine genes in T cells, especially in the
induction of the IL-2 and IL-4. However, there was no evidence of
IL-2 or IL-4 expression in any phase of the host immune response
of our study.
Host Immune Tolerance Subversion of Activated Immune
Related Pathways. Defective sensing and killing of bacteria
may drive the onset of chronic diseases like Johne’s and Crohn’s
[49]. Although there are signs that the host is sensing the presence
of MAP by generating an immune response in all phases, MAP
successfully invades and evades the host immune processes. More
specifically, the major immune related pathways that were
activated in the Early Phase included the Toll-like Receptor
Signaling, Hematopoietic Cell Linage, Adipocytokine Signaling
Pathway, CD40L Signaling, Wnt Signaling, Cytokine-Cytokine
Receptor Interactions, Complement and Coagulation Cascades,
and Lectin Induced Complement pathways. Further examination
of several of these pathways at the network level provided evidence
that MAP was potentially interfering with their immune response
functionalities.
Toll-like ReceptorSignaling (TLRS) Pathway
Subversion. With the triggering of the TLRS pathway, it could
be presumed that the host had initiated an effective immune
response. Examining this pathway at the network and gene
expression level indicates that the source of pathway perturbation
comes from genes that are both highly up-regulated and down-
regulated over the complete time course. Figure 6 shows the
Bayesian network for TLRS pathway and the Bayesian z-score
gene expression temporal heat map for all genes on this pathway.
The toll-like receptor signaling appears defective in that it is not
producing the expected expression patterns for proinflammatory
cytokines. The key cytokines, IL-1b, TNF, IL-6, and IL-12 are not
significantly expressed, although IL-1b is eventually up-regulated
in the Late Phase. Also of interest are the chemokines CCL3 (MIP-
1a), CCL5(RANTES), CXCL9, CXCL10, and CXCL11 which are
not significantly expressed and suggests a potential disruption of
monocyte and natural killer cell stimulation and T-cell migration
that could explain, in part, the host immune tolerance for MAP. In
the early and intermediate phase of MAP invasion, there is
Table 6. Key Down-Regulated Mechanistic Genes for Cell Adhesion and Integrin-Mediated Cell Adhesion Pathways.
ITGB1 integrin, beta 1 (fibronectin receptor) encodes an integrin membrane receptor involved in cell adhesion and a
number of processes including immune response
PTK2 protein tyrosine kinase 2 encodes cytoplasmic protein tyrosine kinase which is found concentrated
in the focal adhesions
MAP2K1 mitogen-activated protein kinase kinase 1 encodes a member of the dual specificity protein kinase family that lies
upstream of MAP kinases and stimulates the enzymatic activity of MAP
kinases upon wide variety of extra- and intracellular signals
SELL selectin L (lymphocyte adhesion molecule 1 encodes a cell surface adhesion molecule that belongs to a family of
adhesion/homing receptors
MAPK1 mitogen-activated protein kinase 1 a gene encoding a member of the MAP kinase family known as extracellular
signal-regulated kinases (ERKs) which act as an integration point for
multiple biochemical signals, and are involved in a wide variety of cellular
processes such as proliferation, differentiation, transcription regulation, and
development
Mpzl1 myelin protein zero-like 1 encodes a cell surface receptor and is believed to be involved in regulation
of integrin-mediated cell motility
CD99 CD99 molecule encodes a cell surface glycoprotein involved in leukocyte migration, T-cell
adhesion, ganglioside GM1 and transmembrane protein transport, and T-
cell death by a caspase-independent pathway
ITGA4 integrin, alpha 4 encodes an integrin alpha chain family protein integral to the membrane
and known to be involved in cellular adhesion/aggregation processes
CLDN7 claudin 7 encodes a member of the claudin family which includes integral membrane
proteins and components of tight junction strands that serve as a physical
barrier to prevent solutes and water from passing freely through the
paracellular space between epithelial or endothelial cell sheets and also
play critical roles in maintaining cell polarity and signal transductions
doi:10.1371/journal.pone.0042127.t006
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significant expression of TLR4, TLR3 and TLR9, but no TLR2 at
any phase. TLR4 is expressed on the cell surface of enterocytes
and numerous cells of the immune system such as dendritic cells, B
lymphocytes and NK cells. On the other hand, MAP can also
interact with TLR9 located within the endosomal compartments of
phagocytic cells and B lymphocytes and functions to alert the
immune system of MAP infections. The lack of TLR2 expression
appears contrary to published results for in vitro M. paratuberculosis
infected murine macrophages in which it was concluded that
TLR2 is one of the key recognition receptors [50,51]. This could
imply that the in vivo pathogenesis of MAP has differing invasion
mechanism than in vitro, or the mechanisms are different between
host species. Also there is no significant expression for MYD88 or
NFkb1 until the late phase in which NFkb1 eventually becomes
significantly expressed.
Hematopoietic Cell Lineage (HCL) Pathway
Subversion. The activation of the HCL pathway may also be
an indicator of host immune response to MAP. The key genes that
dominate the activation of HCL pathway are IL-4R, CD14, CD59,
GYPA, FLT3 and CSF1R. The biological roles of these genes are
described in Table 13. Interleukin-4R is a receptor for both IL-4
and IL-13 and couples to the JAK1/2/3-STAT6 pathway. The
Table 7. Up-Regulated Mechanistic Genes for Cell Adhesion Pathway in Intermediate and Late Phases.
PDPK1 3-phosphoinositide dependent protein kinase-1 May play a role in signaling processes and phosphorylates
and activates PKB/AKT.
CNTN1 contactin 1 Encodes a member of the immunoglobulin superfamily
proteins and is an anchored neuronal membrane protein
which functions as a cell adhesion molecule
NRXN3 neurexin 3 Encodes a protein that functions in the vertebrate nervous
system as cell adhesion molecules
SPN sialophorin CSPG2 Encodes major glycoproteins of thymocytes and T
lymphocytes and plays a role in the physicochemical
properties of the T-cell surface and in lectin binding, and
in some B lymphocytes, where it appears to be important
for immune function and may be part of a physiologic
ligand-receptor complex involved in T-cell activation
CSPG2 Chondroitin sulfate proteoglycan 2 Encodes a member of the aggrecan/versican proteoglycan
family protein involved in cell adhesion, proliferation,
migration and angiogenesis and may play a role in
intercellular signaling and in connecting cells with the
extracellular matrix
HLA-DOB major histocompatibility complex class II, DO beta encodes a MHC class II protein that is an important
modulator in the antigen presentation pathway by
interaction with the HLA-DM molecule in B cells
SELP selectin P, antigen CD62 Encodes a protein important for leukocyte-endothelial cell
adhesion and mediates the interaction of activated
endothelial cells or platelets with leukocytes
PTPRC protein tyrosine phosphatase, receptor type, C Encodes a member of the protein tyrosine phosphatase
(PTP) family. PTPs are known to be signaling molecules
that regulate a variety of cellular processes, including cell
growth, differentiation, mitotic cycle, and oncogenic
transformation and is an essential regulator of T- and B-cell
antigen receptor signaling
ITGAM integrin, alpha M (complement component 3 receptor 3 subunit) Encodes the protein integrin alpha-M/beta-2 and is
implicated in various adhesive interactions of monocytes,
macrophages and granulocytes as well as in mediating the
uptake of complement-coated particles
TLN1 talin 1 encodes a cytoskeletal protein that is concentrated in
areas of cell-substratum and cell-cell contacts and plays a
significant role in the assembly of actin filaments and in
spreading and migration of various cell types, including
fibroblasts and osteoclasts
NCAM1 neural cell adhesion molecule 1 Encodes a cell adhesion protein that is a member of the
immunoglobulin superfamily that is involved in cell-to-cell
interactions as well as cell-matrix interactions during
development and differentiation. This protein has been
shown to also be involved in development of the nervous
system, and for cells involved in the expansion of T cells
and dendritic cells which play an important role in
immune surveillance receptors
RHOC ras homolog gene family, member C encodes a member of the Rho family of small GTPases,
which cycle between inactive GDP-bound and active GTP-
bound states and function as molecular switches in signal
transduction cascades. Rho proteins promote
reorganization of the actin cytoskeleton and regulate cell
shape, attachment, and motility
doi:10.1371/journal.pone.0042127.t007
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IL-4 response is involved in promoting Th2 cell differentiation.
CD14 is a surface antigen that is preferentially expressed on
monocytes/macrophages. It cooperates with other proteins to
mediate the innate immune response to bacterial lipopolysaccha-
ride. CD59 regulates complement-mediated cell lysis, and it is
involved in lymphocyte signal transduction and is a potent
inhibitor of the complement membrane attack complex while also
playing a role in signal transduction pathways in the activation of
T cells. GYPA is a major sialoglycoprotein of the erythrocyte
membrane. Interestingly this protein has been linked to receptor-
ligand interactions involved in the invasion of erythrocytes by
malarial parasite [52] and may suggest a similar MAP influence.
FLT3 and its ligand FLT3LG play an important role in the
immune response by regulating the functions of granulocytes/
macrophage. As observed in our study, the FLT3LG gene
expression was significantly down-regulated in the early phase
and then up-regulated in the late phase. Inhibition of FLT3LG has
been shown to significantly impair the immune system, as well as
cause a reduction in myeloid progenitor cells. The number of B-
cell progenitors, dendritic cells and natural killer cells have been
reported to be significantly reduced in in vivo murine studies [53].
This suggests another evasion mechanism of MAP during the
Early Phase that subverts the host immune response. CSF1R is the
receptor for colony stimulating factor 1, a cytokine that controls
the production, differentiation, and function of macrophages. This
gene was up-regulated only at 30 minutes post-infection and was
down-regulated in the intermediate and late phase suggesting a
longer term mechanism of host immune tolerance to MAP. Our
study clearly indicates that the host responses to MAP starts
immediately after sensing the microbial interaction with the
intestinal mucosa that in turn normally releases signals to stimulate
recruitment of pro-inflammatory leucocytes, immune cells, or
both.
CD40L Signaling Pathway Subversion. Interaction be-
tween CD40L on activated T-cells and CD40 receptors on
macrophages is crucial for maintaining a Th1 response and
activation of macrophages [54]. The CD40L (ligand) signaling
pathway was activated in the Early Phase, tended to be suppressed
in the Intermediate Phase and strongly activated in the Late Stage
as shown in Figure 1. CD40 relies on interaction with TRAF
proteins to mediate an intracellular signal in response to CD40L
binding. The pathway downstream of TRAFs activates the
transcription factor NF-kB through 3 different kinase pathways
involving MAP-kinases, NIK (NF-kB inducing kinase) and I-kB
kinases [55]. All three of these kinases were down-regulated during
MAP infection. Thus, during MAP infection, the antigen receptors
of T-cells were stimulated; however, due to the lack of co-
stimulator molecules from APCs, further T-cell activation
apparently was greatly reduced, reducing the host response of
immune activation to a level approaching an anergic state at the
level of the intestine and influence the disease progression from
paucibacillary form to the multibacillary form of the disease.
Cytokine-Cytokine Receptor Interactions (CCRI)
Pathway Activation. The CCRI pathway was strongly activat-
ed in all three phases with only a few receptors dominating the
activation. These genes were involved in extracellular membrane
Table 8. Key Down-Regulated Mechanistic Genes of the Trefoil Factors Initiated Mucosal Healing Pathway.
PTK2 protein tyrosine kinase 2 Encodes a cytoplasmic protein tyrosine kinase that is
found concentrated in the focal adhesions that form
between cells growing in the presence of extracellular
matrix constituents. The encoded protein is a member of
the FAK subfamily of protein tyrosine kinases.
ITGB1 integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29) Encodes the integrin beta 1 protein which is a
membrane receptor involved in cell adhesion and
recognition in a variety of processes including
embryogenesis, hemostasis, tissue repair, immune
response and metastatic diffusion of tumor cells.
MAPK1 mitogen-activated protein kinase 1 Agene encoding a member of the MAP kinase family
known as extracellular signal-regulated kinases (ERKs)
which act as an integration point for multiple
biochemical signals, and are involved in a wide variety of
cellular processes such as proliferation, differentiation,
transcription regulation, and development
CTNNB1 catenin beta 1 Agene encoding a protein necessary for the creation and
maintenance of epithelial cell layers by regulating cell
growth and adhesion between cells and also anchors the
actin cytoskeleton
doi:10.1371/journal.pone.0042127.t008
Table 9. Up-Regulated Phospholipase Mechanistic Genes and Their Pathway Overlaps.
Gene Pathway Overlaps
PLA2G1B GnRH Signaling, Longterm Depression, VEGF Signaling, MAPK Signaling
PLCB4 GnRH Signaling, Longterm Depression, Phosphatidylinositol Signaling System, Calcium Signaling, Gap Junction, Wnt Signaling
PLD1 GnRH Signaling, Glycerophospholipid metabolism
PLCD1 Phosphatidylinositol Signaling System, Calcium Signaling
doi:10.1371/journal.pone.0042127.t009
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receptor interaction that included chemokines (CC and CXC),
interleukins (ILs), platelet-derived growth factors (PDGFs), and
tumor necrosis factors (TNFs). Chemokines and their receptors are
important for the migration of various cell types into inflammatory
sites. Only the genes CCR4, CXCL9, BLR1 and CCR8 were highly
up-regulated in the Early Phase, while the remaining chemokines
where moderately down-regulated or not expressed in this Phase.
In the Intermediate and Late Phases, the previous chemokines
were not expressed and the following chemokines become strongly
up-regulated: CCL24, CX3CL1, CCL8, and CCL20 while CXCL11
become strongly down-regulated. CCR4 is a receptor for CCL5,
and CXCL11 is chemotactic for activated T cells. BLR1 also known
as CXCR5, has a role in Peyer’s patch primary follicles relating to
B cell migration [56]. The biological roles of these genes are
described in Table 14. Studies of the CCL8 receptor and its
ligands suggested its role in regulation of monocyte chemotaxis
and thymic cell apoptosis. More specifically, this receptor may
contribute to the proper positioning of activated T cells within the
antigenic challenge sites and specialized areas of lymphoid tissues
[57]. The gene CCL20 may be involved in formation and function
of the mucosal lymphoid tissues by attracting lymphocytes and
dendritic cells towards epithelial cells.
The function of the immune system depends in a large part on
Interleukins that are predominately synthesized by helper CD4+ T
lymphocytes, as well as through monocytes, macrophages, and
endothelial cells. Interleukins promote the development and
differentiation of T, B, and hematopoietic cells. The strongly
expressed interleukins in the Early Phase include IL-4R, IL-18RAP
and IL-17RB. IL-4R reverses expression direction and was
strongly down regulated in the Intermediate and Late Phase.
The strongly up-regulated ILs in the Intermediate and Late Phase
include IL-1B, IL-18RAP, IL-7, IL-8RB, and IL-6 while the
strongly down-regulated genes include IL-13, IL-15, IL-1A, and
IL-4R. The biological roles of these genes are described in
Table 15. The soluble epithelial factors (IL-7 and IL-15)
differentially regulate homeostasis of intraepithelial lymphocytes
and other mucosal leukocytes. IL7 can be produced locally by
intestinal epithelial and epithelial goblet cells, and may serve as a
regulatory factor for intestinal mucosal lymphocytes. The IL8RB is
a receptor for IL8 and mediates neutrophil migration to sites of
inflammation. The angiogenic effects of IL8 in intestinal
microvascular endothelial cells are mediated by this receptor.
Leukocytes play an important role in the maintenance of epithelial
barrier. Interestingly, the gene, IL-13, is known to be critical in
regulating immune response, but it was strongly down-regulated in
the host response and may be important to MAP survival long
term.
The elevated expression of platelet-derived growth factors
(PDGF) have been linked to early signaling events for infection
by intracellular pathogens [58]. PDGF genes and their receptors
that were strongly up-regulated in the Early Phase include VEGFB,
FLT3, FLT3LG, and CSF1R. VEGFB signals via the endothelial
receptor FLT1 and is a regulator of blood vessel physiology, with a
role in endothelial targeting of lipids to peripheral tissues. FLT3
encodes a class III receptor tyrosine kinase that regulates
hematopoiesis. CSF1R encodes a tyrosine kinase transmembrane
receptor and is involved in the functions of macrophages.
Expression levels subsided for VEGFB, FLT2LG, and CSF1R in
the Intermediate and Late Phase, but FLT3 was triphasic, in that it
was highly up-regulated in the Early Phase, highly down-regulated
in the Intermediate Phase and becomes highly up-regulated in the
Late Phase. Only FLT1 and VEGFC were up-regulated in the
Intermediate and Late Phases while KDR and PDGFC were
strongly down-regulated. FLT1 encodes a receptor tyrosine-kinase
and plays a key role in vascular development and regulation of
vascular permeability. VEGFC encodes a PDGF that has a role in
endothelial cell growth, stimulating their proliferation and
migration and also has effects on the permeability of blood vessels.
The down-regulated KDR gene encodes one of the two receptors of
the VEGF and is a main mediator of VEGF-induced endothelial
proliferation, survival, migration, tubular morphogenesis and
sprouting. The down-regulated gene PDGFC is a receptor with
tyrosine-kinase activity that has roles in the regulation of many
biological processes including embryonic development, angiogen-
Table 10. Mechanistic Genes of the Phosphatidylinositol Signaling System.
Up-Regulated Mechanistic Genes
PLCD1 phospholipase C, delta 1 Encodes phosphoinositide-specific phospholipase C that acts as a signal
transducer and has diverse biological functions including roles in
inflammation, cell growth, signaling and death and maintenance of
membrane phospholipids
PLCB4 phospholipase C, beta 4 The protein encoded by this gene catalyzes the formation of inositol 1,4,5-
trisphosphate and diacylglycerol from phosphatidylinositol 4,5-
bisphosphate. This reaction uses calcium as a cofactor and plays an
important role in the intracellular transduction of many extracellular signals
INPP4A inositol polyphosphate-4-phosphatase, type I Encodes an Mg++ independent enzyme that hydrolyzes the 4-position
phosphate from the inositol ring of phosphatidylinositol 3,4-bisphosphate,
inositol 1,3,4-trisphosphate, and inositol 3,4-bisphosphate. This reaction
uses calcium as a cofactor and plays an important role in the intracellular
transduction of many extracellular signals similar to PLCD1
ITPR2 inositol 1,4,5-trisphosphate receptor, type 2 Encode receptors for inositol 1,4,5-trisphosphate, a second messenger that
mediates the release of intracellular calcium
ITPR3 inositol 1,4,5-trisphosphate receptor, type 3 Encode receptors for inositol 1,4,5-trisphosphate, a second messenger that
mediates the release of intracellular calcium
Down-Regulated Mechanistic Genes
CALM2 calmodulin 2 The protein encoded by CALM2 mediates the control of a large number of
enzymes and other proteins by Ca++ and is involved in a genetic pathway
that regulates the centrosome cycle and progression through cytokinesis
doi:10.1371/journal.pone.0042127.t010
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esis, cell proliferation and differentiation, and contribute to the
pathophysiology of some diseases, including cancer. Biological
roles of these genes are provided in Table 16.
Adipocytokine Signaling (AS) Pathway
Manipulation. The activated AS pathway may be a novel
pathway associated with MAP invasion. Several adipocytokines
have been found to have a central role in the regulation of
inflammation and immunity [59] and may be important as
another MAP host evasion strategy. Adipocytokines exert different
effects on the innate immune system and either suppress or
activate the monocyte–macrophage system. ADIPOQ (gene
encoding adiponectin) through interaction with its receptor
ADIPOR1 (and ADIPOR2) suppresses the NF-kB-dependent
synthesis of tumour-necrosis factor (TNF) and interferon (IFN).
Adiponectin also induces apoptosis of monocytes and inhibits
phagocytosis by macrophages.
Wnt Signaling (WS) Pathway Activation. In our study, Wnt
signaling, which was a highly scored pathway during the Early
Phase, is known to be associated with regeneration of nervous
system cells using an integrative computational model for intestinal
tissue renewal [60]. Planar cell polarity signaling is one of the
downstream pathways in the Wnt signaling, and it leads to the
activation of the small GTPases and Rac-1. Rac-1, one of the
mechanistic genes identified in our study, may regulate cell
adhesion and epithelial cell motility in response to MAP entry. In
neurons, Rac-1 acts through the protein kinase cdk5 and p35 to
phosphorylate and down-regulate Pak1, increasing neuronal
migration. Rac-1 also interacts with several other factors to
Table 11. Mechanistic Genes of the Microtubule-Associated Protein 1 Pathway.
Early Phase Up-Regulated Mechanistic Genes
SNAP23 synaptosomal-associated protein, 23 kDa Encodes a protein structurally and functionally similar to
SNAP25 and binds tightly to multiple syntaxins and
synaptobrevins/VAMPs. It is an essential component of the
high affinity receptor for the general membrane fusion
machinery and is an important regulator of transport vesicle
docking and fusion.
Vamp2 vesicle-associated membrane protein 2 Encodes a protein that is a member of the vesicle-associated
membrane protein (VAMP)/synaptobrevin family.
Synaptobrevins/VAMPs, syntaxins, and the 25-kD
synaptosomal-associated protein SNAP25 are the main
components of a protein complex involved in the docking
and/or fusion of synaptic vesicles with the presynaptic
membrane. This gene is thought to participate in
neurotransmitter release at a step between docking and
fusion.
Early Phase Down-Regulated Mechanistic Genes
Vti1a vesicle transport through interaction with t-SNAREs homolog 1A V-SNARE that mediates vesicle transport pathways through
interactions with t-SNAREs on the target membrane. These
interactions are proposed to mediate aspects of the specificity
of vesicle trafficking and to promote fusion of the lipid
bilayers. Involved in vesicular transport from the late
endosomes to the trans-Golgi network
YKT6 YKT6 v-SNARE homolog (S. cerevisiae) Encodes a protein that is a member of the SNARE recognition
molecules implicated in vesicular transport between secretory
compartments. Functions in endoplasmic reticulum to Golgi
transport; as part of a SNARE complex composed of GOSR1,
GOSR2 and STX5. Functions in early/recycling endosome to
TGN transport; as part of a SNARE complex composed of
BET1L, GOSR1 and STX5.
Late Phase Down-Regulated Mechanistic Genes
Vti1b vesicle transport through interaction with t-SNAREs homolog 1B V-SNARE that mediates vesicle transport pathways through
interactions with t-SNAREs on the target membrane. These
interactions are proposed to mediate aspects of the specificity
of vesicle trafficking and to promote fusion of the lipid
bilayers. May be concerned with increased secretion of
cytokines associated with cellular senescence.
STX8 CIP-1-associated regulator of cyclin B The gene is a member of the syntaxin family. The encoded
protein is involved in protein trafficking from early to late
endosomes via vesicle fusion and exocytosis.
STX10 syntaxin 10 SNARE involved in vesicular transport from the late
endosomes to the trans-Golgi network
STX6 syntaxin 6 Involved in intracellular vesicle trafficking
YKT6 Same as above.
GOSR2 golgi SNAP receptor complex member 2 Encodes a trafficking membrane protein which transports
proteins among the medial- and trans-Golgicompartments.
Due to its chromosomal location and trafficking function, this
gene may be involved in familial essential hypertension.
doi:10.1371/journal.pone.0042127.t011
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regulate enteric neuronal network. Neurexophilins (neuropeptide-like
proteins) and neurexins also participate in a neuron signaling
pathway [61–63]. Neuronactin and contactin transmembrane proteins
are also known to mediate cell-cell interactions in nervous system
[64]. Neurexins contain epidermal growth factor-like sequences and
domains homologous to the G domain repeats of laminin A, as
related to its function in ileal mucosa and cell-cell interactions.
Intestinal motility is affected by the invading enteric pathogens. A
number of gastrointestinal hormones appear to affect intestinal
motility [65]. Interestingly, it was shown earlier that the enteric
nervous system is involved in inflammatory bowel disease in which
MAP is associated [66,67]. In cattle and sheep with Johne’s
disease, myenteric ganglionitis with cellular infiltration occurs
[68]. During the experimental inoculation of sheep with MAP,
Table 12. Mechanistic Genes of the Calcium Signaling Pathway.
Up-Regulated Mechanistic Genes in All Three Immune Response Phases
NFATC4 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 Encodes a protein that is member of the nuclear factors of
activated T cells DNA-binding transcription complex that
plays a role in the inducible expression of cytokine genes
in T cells, especially in the induction of the IL-2 and IL-4.
CAMK2A calcium/calmodulin-dependent protein kinase II alpha Encodes protein that belongs to the serine/threonine
protein kinases family, and to the Ca(2+)/calmodulin-
dependent protein kinases (CaMKs) subfamily. CaMKs have
numerous cellular functions and they influence processes
as diverse as gene transcription, cell survival, apoptosis,
and cytoskeletal re-organization.
PLCB3 phospholipase C, beta 3 (phosphatidylinositol-specific Encodes a member of the phosphoinositide
phospholipase C beta enzyme family that catalyze the
production of the secondary messengers diacylglycerol
and inositol 1,4,5-triphosphate from phosphatidylinositol
in G-protein-linked receptor-mediated signal transduction.
Phospholipases are ubiquitously expressed and have
diverse biological functions including roles in
inflammation, cell growth, signaling and death and
maintenance of membrane phospholipids.
Early Phase Only Up-Regulated Mechanistic Genes
ADCY8 adenylate cyclase 8 Encodes a protein that is a membrane bound enzyme that
catalyses the formation of cyclic AMP from ATP
EDNRB endothelin receptor type B Encodes a G protein-coupled receptor which activates a
phosphatidylinositol-calcium second messenger system.
NFKBIB nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta Encodes a protein that Inhibits NF-kappa-B by complexing
with and trapping it in the cytoplasm. However, the
unphosphorylated form resynthesized after cell
stimulation is able to bind NF-kappa-B allowing its
transport to the nucleus and protecting it to further
NFKBIA-dependent inactivation.
TACR2 tachykinin receptor 2 Encodes the receptor for the tachykinin neuropeptide
substance K, also referred to as neurokinin A (NK). This
neurokinin 2 (NK2) receptor is a member of the tachykinin
family of G-protein-coupled receptors. The NK2 receptor is
predominantly expressed in the periphery gastrointestinal
smooth muscle). NK2 receptors are thought to mediate
gastrointestinal contraction and airway and lung function.
Early Phase Only Down-Regulated Mechanistic Genes
CALM2 calmodulin 2 (phosphorylase kinase, delta) Mediates the control of a large number of enzymes and
other proteins by Ca(2+) and is involved in a genetic
pathway that regulates the centrosome cycle and
progression through cytokinesis.
PPID peptidylprolyl isomerase D Encodes a member of the peptidyl-prolylcis-trans
isomerase (PPIase) family. PPIases catalyze the cis-trans
isomerization of proline imidic peptide bonds in
oligopeptides and accelerate the folding of proteins.
GNAQ guanine nucleotide binding protein (G protein), q polypeptide Encodes the guanine nucleotide binding protein that
couples a seven-transmembrane domain receptor to
activation of phospolipase C-beta.
ATP2B4 ATPase, Ca++ transporting, plasma membrane 4 Encodes a protein belonging to the family of P-type
primary ion transport ATPases characterized by the
formation of an aspartyl phosphate intermediate during
the reaction cycle. These enzymes remove bivalent
calcium ions from eukaryotic cells against very large
concentration gradients and play a critical role in
intracellular calcium homeostasis.
doi:10.1371/journal.pone.0042127.t012
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some sheep developed aggregations of mononuclear cells around
enteric nerves in the ileal submucosa and myenteric plexus [69].
However, such lesions were not detected in sheep that did not
subsequently develop classical disease manifestations. At this
juncture, it is not clear if the Johne’s disease is also an outcome
of the enteric neuropathy that starts when MAP colonizes in the
intestine. Thus, further studies are warranted to understand the
correlation between MAP colonization and enteric neuropathy.
Furthermore, neurotrophins are known to activate two different
classes of receptors, the Trk family of receptor tyrosine kinases and
p75NTR, a member of the TNF receptor superfamily. Our gene
expression data indicate that neurotrophins may be activating
TNF receptor superfamily. This interaction may in turn activate
many signaling pathways, including those mediated by ras and
members of the cdc-42/ras/rho G protein families, and by the MAP
kinase, PI-3 kinase, and Jun kinase cascades.
Mitogen-activated Protein Kinase 1 (MAPK1) Influence on
MAP invasion. In our study we focused on the MAPK1 gene.
The protein encoded by MAPK1 is a member of the MAP kinase
family. MAP kinases, also known as extracellular signal-regulated
kinases (ERKs), act as an integration point for multiple biochem-
ical signals, and are involved in a wide variety of cellular processes
such as proliferation, differentiation, transcription regulation and
development. Unlike other pathogens, MAP did not exhibit
increased invasion or replication during the 12 hr post-infection,
though MAP was in continuous contact with host Peyer’s patch in
the ligated ileal loop [2]. To provide evidence that inhibition in the
entry of MAP is MAPK1 dependent, we specifically knocked down
in vitro MAPK1 gene expression in HeLa cells by siRNA. The
invasion of MAP in HeLa cells was highly significantly reduced
when we silenced MAP kinase by introducing siRNA (Figure 7).
Thus, MAP kinase is probably one of the key genes influencing
invasion of MAP.
Host Immune Tolerance: Suppressed Immune Related
Pathways
Pathways that are suppressed may be assumed to be an
indicator of MAP host processes that are hi-jacked, but in a way to
subvert the host’s defensive response. The One Carbon Pool by
Folate, Long-term Potentiation, Long-term Depression, and
CCR3 Signaling in Eosinophils pathways are potentially hi-jacked
processes suppressed in the Early Phase. Further examination of
these pathways at the network level provided evidence that MAP
was potentially interfering with their immune response function-
ality.
One Carbon Pool By Folate (OCPF) Pathway
Suppression. The OCPF pathway is suppressed in the Early
Phase, was tri-phasic (suppressed, activated, and suppressed) in the
Intermediate Phase and was strongly activated in the Late Phase as
shown in the pathway heat map of Figure 1. This pathway may be
novel to MAP pathogenicity and its impairment may adversely
impact genome integrity, disrupt establishment of other metabolic
Figure 6. Toll-like Receptor Signaling Pathway. Toll-like receptor signaling pathway Bayesian network representation at 30 min post-infection
(left), and the DBGGA scores for the gene expression of MAP infected host Peyer’s patch versus non-infected controls (right). Gene nodes with orange
circles on the network are those defined as mechanistic genes that surpass a threshold |Bayesian z-score|.2.24. The network shows gene nodes with
gradient colors representing the level of expression (deeper red for higher up-regulated genes and deeper green for down-regulated). The heat map
is colorized and corresponds to the gene node expression levels. Grey color represents little to no expression difference between MAP infected and
controls. The heat map columns are by time post-infection in minutes.
doi:10.1371/journal.pone.0042127.g006
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pathways and mechanisms that underlie folate-associated pathol-
ogies. A previous study [70] found that folate deficiency inhibits
the proliferation of primary CD8+ T Lymphocytes, another
possible mechanism underlying host immune tolerance of MAP.
Within the One Carbon Pool by Folate pathway are three strongly
down-regulated genes (Early Phase) that include MTHFD1,
MTHFD2, and GART. In the Late phase, GART reversed to
become strongly up-regulated while MTHFD1 and MTHFD2
reduced expression levels to a moderate insignificant level. A
review of the literature found MTHFD1 and MTHFD2 to have
some association with immune response. The MTHFD1 encodes a
protein that possesses three distinct enzymatic activities that are
essential cofactors for thymidylate and purine synthesis [71].
Disorders of purine metabolism lead to immunodeficiency having
marked susceptibility to infection [72]. Interestingly, the protein
encoded byMTHFD2 was found to have highly fluctuating protein
abundance levels over time in mouse macrophages infected with
Salmonella enterica [73]. This suggests that MTHFD1 and MTHFD2
may be novel to the MAP invasion mechanisms and may warrant
further examination in future studies. More details of the
biological role of these genes are provided in Table 17.
Long-term Potentiation (LTP) and Long-term Depression
(LTD) Pathway Suppressions. Other novel pathways sup-
pressed in the early phase and reversed to an activated state in the
late phase are the LTP and LTD pathways. MAP pathogenicity
appears to have interaction with neuronal activity, the mecha-
nisms of which are not well understood. The dominating genes
causing the pathways’ suppressed scores are PPP1CA, PPP1CB,
MAPK1, GNAI3, GNAO1, IGFR1, and Gucy2c. The biological roles
of these genes are provided in Table 18. Recently, it was found
that Gucy2c is involved in regulating AKT-dependent intestinal
barrier integrity [74]. GNAI3 has been linked as an important
participant in lymphocyte position and chemokine receptor
signaling in B cells [75].
Table 13. Mechanistic Genes for the Hematopoietic Cell Lineage (HCL) Pathway.
IL-4R interleukin 4 receptor Encodes the alpha chain of the interleukin-4 receptor, a type I
transmembrane protein that can bind interleukin 4 and interleukin 13
to regulate IgE production. The encoded protein also can bind
interleukin 4 to promote differentiation of Th2 cells. Receptor for both
interleukin 4 and interleukin 13. Couples to the JAK1/2/3-STAT6
pathway. The IL4 response is involved in promoting Th2
differentiation. The IL4/IL13 responses are involved in regulating IgE
production and, chemokine and mucus production at sites of allergic
inflammmation.
CD14 CD14 molecule Encodes a surface antigen that is preferentially expressed on
monocytes/macrophages. It cooperates with other proteins to
mediate the innate immune response to bacterial lipopolysaccharide.
Cooperates with MD-2 and TLR4 to mediate the innate immune
response to bacterial lipopolysaccharide (LPS). Acts via MyD88, TIRAP
and TRAF6, leading to NF-kappa-B activation, cytokine secretion and
the inflammatory response.
Up-regulates cell surface molecules, including adhesion molecules.
CD59 CD59 molecule, complement regulatory protein Encodes a cell surface glycoprotein that regulates complement-
mediated cell lysis, and it is involved in lymphocyte signal
transduction. This protein is a potent inhibitor of the complement
membrane attack complex, whereby it binds complement C8 and/or
C9 during the assembly of this complex, thereby inhibiting the
incorporation of multiple copies of C9 into the complex, which is
necessary for osmolytic pore formation. This protein also plays a role
in signal transduction pathways in the activation of T cells. Involved in
signal transduction for T-cell activation complexed to a protein
tyrosine kinase
GYPA glycophorin A (MNS blood group) Encodes a major sialoglycoproteins of the human erythrocyte
membrane which bear the antigenic determinants for the MN and Ss
blood groups.
FLT3 fms-related tyrosine kinase 3 This gene encodes a class III receptor tyrosine kinase that regulates
hematopoiesis. The receptor consists of an extracellular domain
composed of five immunoglobulin-like domains, one transmembrane
region, and a cytoplasmic kinase domain split into two parts by a
kinase-insert domain. The activated receptor kinase subsequently
phosphorylates and activates multiple cytoplasmic effector molecules
in pathways involved in apoptosis, proliferation, and differentiation of
hematopoietic cells in bone marrow.
CSF1R colony stimulating factor 1 receptor Encodes the receptor for colony stimulating factor 1, a cytokine which
controls the production, differentiation, and function of macrophages.
This receptor mediates most if not all of the biological effects of this
cytokine.
FLT3LG fms-related tyrosine kinase 3 ligand Dendritic cells (DCs) provide the key link between innate and adaptive
immunity by recognizing pathogens and priming pathogen-specific
immune responses. FLT3LG controls the development of DCs and is
particularly important for plasmacytoid DCs and CD8. Stimulates the
proliferation of early hematopoietic cells by activating FLT3.
doi:10.1371/journal.pone.0042127.t013
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CCR3 Signaling in Eosinophils (CSE) Pathway
Suppression. In our study, CSE pathway was strongly sup-
pressed in the Early Phase, inactive in the Intermediate Phase, and
moderately suppressed in the Late Phase. CSE pathway suppression
may be a key mechanism that supports the host tolerance to MAP.
Eosinophils are a key class of leukocytes involved in inflammatory
responses. Blocking eosinophil activation and the signaling path-
ways that lead to chemotaxis, degranulation and reactive oxygen
release may alleviate inflammatory conditions and inflammation-
associated tissue damage which may be a longer term survival
mechanism of MAP. A number of genes are strongly down-
regulated or not differentially expressed at all during the Early Phase
and the majority of genes are lowly expressed in the Intermediate
and Late Phases. In fact, the gene CCR3 has a low differential
expression across all phases. The protein encoded by CCR3 is a
receptor for C-C type chemokines and belongs to family 1 of the G
protein-coupled receptors. This receptor binds and responds to a
variety of chemokines, including eotaxin (CCL11), eotaxin-3
(CCL26), MCP-3 (CCL7), MCP-4 (CCL13), and RANTES
(CCL5). It is highly expressed in eosinophils and basophils, and is
also detected in TH1 and TH2 cells. The key genes dominating the
suppression of CCR3 Signaling in the Early Phase are GNAQ,
MAP2K1, andMYL2 although there are several other genes that had
a moderate down regulation. Biological roles of these genes are
provided in Table 19. GNAQ was described previously in the
Calcium Signaling pathway. MAP2K1 is an essential component of
MAP kinase signal transduction pathway, involved in many cellular
processes such as proliferation, differentiation, transcription regu-
lation and development and be also be important for eosinophil
chemotaxis. The gene MYL2 encodes the myosin, light chain 2
protein. In CSE pathway, MYL2 is associated with the assembly of
actomysin filaments. It is also involved in muscle contraction
through cyclic interactions with actin-rich thin filaments, creating
acontractile force. CSE pathway suppression may disrupt immune
defenses by alleviating inflammatory conditions. This may signify
another contributingmechanism to host immune tolerance ofMAP.
During the Intermediate Phase of MAP infection, higher levels of
perturbation of signaling and immune response related pathways
reflect active host-pathogen interactions. Autocrine and paracrine
cell-cell signaling are very important for the interaction and
maintenance of homeostasis within the diverse cell population
(enterocytes, dendritic cells, macrophages, eosinophils, mast cells,
and natural killer cells) of the intestinal mucosa [76,77].
Host Immune Tolerance: Non-Responsive Immune
Related Pathways
Pathways that are non-responsive (not activated) may be an
indicator of disrupted host processes by MAP. An interesting
Table 14. Chemokine Mechanistic Genes of the Cytokine-Cytokine Receptor Interactions Pathway.
Early Phase Only Up-Regulated Mechanistic Genes
CCR4 chemokine (C-C motif) receptor 4 Encodes G-protein-coupled receptor family. It is a receptor for the CC chemokine -
MIP-1, RANTES, TARC and MCP-1.
CXCL9 chemokine (C-X-C motif) ligand 9 The function of this gene has not been specifically defined; however, it is thought to
be involved in T cell trafficking.
BLR1 chemokine receptor 5 Encodes a predicted seven transmembrane G protein- coupled receptor and
belongs to the CXC chemokine receptor family, a BLC (B-lymphocyte
chemoattractant). Cytokine receptor that binds to B-lymphocyte chemoattractant
(BLC). Involved in B-cell migration into B-cell follicles of spleen and Peyer patches
but not into those of mesenteric or peripheral lymph nodes. May have a regulatory
function in Burkitt lymphoma (BL) lymphomagenesis and/or B-cell differentiation.
CCR8 chemokine (C-C motif) receptor 8 Encodes a member of the beta chemokine receptor family, which is predicted to be
a seven transmembrane protein similar to G protein-coupled receptors.
Intermediate and Late Phase Only Up-Regulated Mechanistic Genes
CCL24 chemokine (C-C motif) ligand 241 Encodes for a cytokine family of secreted proteins involved in immunoregulatory
and inflammatory processes. Chemotactic for resting T-lymphocytes, and
eosinophils. Has lower chemotactic activity for neutrophils but none for monocytes
and activated lymphocytes. Is a strong suppressor of colony formation by a
multipotential hematopoietic progenitor cell line.
CX3CL1 chemokine (C-X3-C motif) ligand 1 The soluble form is chemotactic for T-cells and monocytes, but not for neutrophils.
The membrane-bound form promotes adhesion of those leukocytes to endothelial
cells. May play a role in regulating leukocyte adhesion and migration processes at
the endothelium. Binds to CX3CR1
CCL8 chemokine (C-C motif) ligand 8 Encodes a protein structurally related to the CXC subfamily of cytokines. This
cytokine displays chemotactic activity for monocytes, lymphocytes, basophils and
eosinophils. By recruiting leukocytes to sites of inflammation this cytokine may
contribute to tumor-associated leukocyte infiltration and to the antiviral state
against HIV infection.
CCL20 chemokine (C-C motif) ligand 20 Chemotactic factor that attracts lymphocytes and, slightly, neutrophils, but not
monocytes. Inhibits proliferation of myeloid progenitors in colony formation assays.
May be involved in formation and function of the mucosal lymphoid tissues by
attracting lymphocytes and dendritic cells towards epithelial cells.
CXCL11 chemokine (C-X-C motif) ligand 11 Encodes a protein that induces a chemotactic response in activated T-cells and is
the dominant ligand for CXC receptor-3. IFN-gamma is a potent inducer of
transcription of this gene. Chemotactic for interleukin-activated T-cells but not
unstimulated T-cells, neutrophils or monocytes. Induces calcium release in activated
T-cells.
doi:10.1371/journal.pone.0042127.t014
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Table 15. Interleukin Mechanistic Genes Cytokine-Cytokine Receptor Interactions Pathway.
Early Phase Only Up-Regulated Mechanistic Genes
IL-4R interleukin 4 receptor Encodes the alpha chain of the interleukin-4 receptor, a type I
transmembrane protein that can bind interleukin 4 and
interleukin 13 to regulate IgE production.
IL-18 interleukin 18(interferon-gamma-inducing factor)), Encodes a proinflammatory cytokine. This cytokine can induce
the IFN-gamma production of T cells. The combination of this
cytokine and IL12 has been shown to inhibit IL4 dependent IgE
and IgG1 production, and enhance IgG2a production of B cells.
IL-18 binding protein (IL18BP) can specifically interact with this
cytokine, and thus negatively regulate its biological activity.
IL-18RAP interleukin 18 receptor accessory protein Encodes an accessory subunit of the heterodimeric receptor for
IL18. This protein enhances the IL18 binding activity of IL18R1
(IL1RRP), a ligand binding subunit of IL18 receptor. Required for
the high affinity binding of interleukin 18 (IL-18) to its receptor
complex (By similarity). Together with IL18R1 mediates IL-18-
dependent activation of NF-kappa-B and JNK
IL-17RB interleukin receptor B Encodeds a cytokine receptor. This receptor specifically binds to
IL17B and IL17E, but does not bind to IL17 and IL17C. This
receptor has been shown to mediate the activation of NF-
kappaB and the production of IL8 induced by IL17E.
Intermediate and Late Phase Only Up-Regulated Mechanistic Genes
IL-1B interleukin 1, beta Encodes a member of the interleukin 1 cytokine family. This
cytokine is produced by activated macrophages as a
proprotein, which is proteolytically processed to its active form
by caspase 1 (CASP1/ICE). This cytokine is an important
mediator of the inflammatory response, and is involved in a
variety of cellular activities, including cell proliferation,
differentiation, and apoptosis.
IL-18RAP See description above
IL-7 interleukin 7 Encodes a cytokine important for B and T cell development.
This cytokine and the hepatocyte growth factor (HGF) form a
heterodimer that functions as a pre-pro-B cell growth-
stimulating factor. This cytokine is found to be a cofactor for
V(D)J rearrangement of the T cell receptor beta (TCRB) during
early T cell development. This cytokine can be produced locally
by intestinal epithelial and epithelial goblet cells, and may serve
as a regulatory factor for intestinal mucosal lymphocytes.
IL-8RB chemokine (C-X-C motif) receptor 2 Encodes a member of the G-protein-coupled receptor family.
This protein is a receptor for interleukin 8 (IL8). It binds to IL8
with high affinity, and transduces the signal through a G-
protein activated second messenger system. This receptor
mediates neutrophil migration to sites of inflammation. The
angiogenic effects of IL8 in intestinal microvascular endothelial
cells are found to be mediated by this receptor.
IL-6 interleukin 6 (interferon, beta 2) Encodes a cytokine that functions in inflammation and the
maturation of B cells. It is a potent inducer of the acute phase
response. Plays an essential role in the final differentiation of B-
cells into Ig-secreting cells Involved in lymphocyte and
monocyte differentiation.
Intermediate and Late Phase Only Down-Regulated Mechanistic Genes
IL-13 interleukin 13 Encodes an immunoregulatory cytokine produced primarily by
activated Th2 cells. This cytokine is involved in several stages of
B-cell maturation and differentiation. Inhibits inflammatory
cytokine production. Synergizes with IL2 in regulating
interferon-gamma synthesis. May be critical in regulating
inflammatory and immune responses.
IL-15 interleukin 15 Encodes a cytokine that regulates T and natural killer cell
activation and proliferation.
IL-1A interleukin 1, alpha Encodes a member of the interleukin 1 cytokine family. This
cytokine is a pleiotropic cytokine involved in various immune
responses, inflammatory processes, and hematopoiesis. This
cytokine is produced by monocytes and macrophages as a
proprotein, which is proteolytically processed and released in
response to cell injury, and thus induces apoptosis.
IL-4R See description above
doi:10.1371/journal.pone.0042127.t015
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finding was that interaction of MAP with the host failed to induce
several key immune related pathways during all three phases of
host response. These pathways included Fc Epsilon RI Signaling,
B cell Receptor (BCR) Signaling, Activation of CSK Through T
Cell Receptor Signaling, Natural Killer Cell Mediated Cytotox-
icity, and T Cell Receptor Signaling. Fc epsilon RI signaling is
exclusive to the mast cells [78]. Suppression of mast cells activity
thus affect the innate responses of the host to release several
activated molecules, such as biogenic amines (histamines),
proteoglycans (heparin), lipid mediators such as leukotrienes
(LTC4, LTD4 and LTE4), prostaglandins (especially PDG2) and
secretion of cytokines, the most important of which are TNF-a,
IL4 and IL5. The suppression of these mediators, cytokines and T-
cell receptors signaling along with the up-regulation in the
epithelial repair mechanisms and reduced inflammation may
enhance MAP intracellular survival and facilitate persistent
infection. BCR Signaling inactivity may imply that any signaling
pathways emanating from the B cell antigens is likely not
stimulating any B lymphocyte immune response.
To further understand the mechanistic events that are
suppressing T-cell activation, the CD40L Signaling (CS) and T-
cell Signaling (TCS) pathways were examined at the gene
expression and network level. Table 20 indicates the DBGGA
gene Bayesian z-score results across the Early, Intermediate and
Late Phases of host immune response for CS pathway that shows a
majority of important genes as not significantly expressed.
Suppression of genes in the CS pathway may have a further
negative regulation on a large number of genes implicated in host
defense against pathogens. For the TCS pathway, the DBGGA
analysis clearly indicated a defective antigen processing and
presentation by MHC class II molecule as shown in Figure 8a. In
this graphical representation of T-cell signaling, several genes
Table 16. Platelet Derived Growth Factors Mechanistic Genes of the Cytokine-Cytokine Interaction Pathway.
Early Phase Only Up-Regulated Mechanistic Genes
VEGFB vascular endothelial growth factor B Vascular endothelial growth factor B (VEGFB) signals via
the endothelial receptor VEGFR1 (MIM 165070) and is a
regulator of blood vessel physiology, with a role in
endothelial targeting of lipids to peripheral tissues
FLT3 fms-related tyrosine kinase 31 Encodes a class III receptor tyrosine kinase that regulates
hematopoiesis. The receptor is activated by binding of the
fms-related tyrosine kinase 3 ligand to the extracellular
domain, which induces homodimer formation in the
plasma membrane leading to autophosphorylation of the
receptor. The activated receptor kinase subsequently
phosphorylates and activates multiple cytoplasmic
effector molecules in pathways involved in apoptosis,
proliferation, and differentiation of hematopoietic cells in
bone marrow.
FLT3LG fms-related tyrosine kinase 3 ligand Stimulates the proliferation of early hematopoietic cells by
activating FLT3. Synergizes well with a number of other
colony stimulating factors and interleukins
CSF1R colony stimulating factor 1 receptor Encodes the receptor for colony stimulating factor 1, a
cytokine which controls the production, differentiation,
and function of macrophages. This receptor mediates
most if not all of the biological effects of this cytokine.
Ligand binding activates the receptor kinase through a
process of oligomerization and transphosphorylation. The
encoded protein is a tyrosine kinase transmembrane
receptor and member of the CSF1/PDGF receptor family of
tyrosine-protein kinases.
Intermediate and Late Phase Only Up-Regulated Mechanistic Genes
FLT1 fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability
factor receptor)
Encodes a receptor tyrosine- kinase and plays a key role in
vascular development and regulation of vascular
permeability. Vascular endothelial growth factor is a
signaling protein involved in the regulation of
angiogenesis and vasculogenesis. VEGF binds to and
activates a receptor tyrosine kinase, VEGFR.
VEGFC vascular endothelial growth factor C Encodes a PDGF that has a role in endothelial cell growth,
stimulating their proliferation and migration and also has
effects on the permeability of blood vessels.
Intermediate and Late Phase Only Down-Regulated Mechanistic Genes
KDR kinase insert domain receptor (a type III receptor tyrosine kinase)) Encodes one of the two receptors of the VEGF and is a
main mediator of VEGF-induced endothelial proliferation,
survival, migration, tubular morphogenesis and sprouting.
PDGFC platelet derived growth factor C Encodes a receptor with tyrosine-kinase activity that has
roles in the regulation of many biological processes
including embryonic development, angiogenesis, cell
proliferation and differentiation, and contribute to the
pathophysiology of some diseases, including cancer.
doi:10.1371/journal.pone.0042127.t016
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encoding MHC molecules were not differentially expressed. MAP
infection did not change the expression level of co-stimulatory
molecules (CD28, CD24, CD40LG and CD80) that are known to be
involved in the activation of PI3K and GRB2 that finally activate
NFkB. Interestingly, during MAP infection, LCK and NFATC1
(nuclear factor of activated T-cells, cytoplasmic, calcineurin-
dependent 1), NFATC4 (nuclear factor of activated T-cells,
cytoplasmic, calcineurin-dependent 4) are the mechanistic genes
in T-cell signaling pathway and activation of these genes leads to
ubiquitin-mediated proteolysis. The NFATC1 and NFATC4 genes
were common mechanistic genes in VEGF signaling pathway and
T-cell receptor signaling pathway. NFATC1 was strongly down-
regulated in the Early Phase and up-regulated in the Late Phase
while NFATC4 was only strongly up-regulated in the Early Phase.
The products of NFATC1 and NFATC4 genes play a role in the
inducible expression of cytokine genes in T-cells, especially in the
induction of the IL-2 or IL-4 gene transcription that, in our study,
were not differentially expressed. These gene products are also
involved in regulation, activation, proliferation and differentiation
of T-cells as well as lymphoid and non-lymphoid cells. Several of
these genes are involved in maintaining a fine balance between
immunity and tolerance.
Moreover, the expression of all the genes related to MHC
molecules (HLA-DMA, HLA-A, HLA-DQB2, HLA-DRA, HLA-
DQA1, HLA-DMB, HLA-DOA, HLA-DOB) were not differentially
expressed or tended to be down-regulated the entire period of our
experiments (Figure 8b). Full T-cell activation requires: 1) binding
of the T-cell receptor to the antigen-MHC complex on the antigen
presenting cell, and 2) a co-stimulatory signal provided by the
binding of the T-cell’s CD28 protein to the B7 protein on the
Antigen Presenting Cell (APC). In our study, MAP infection
resulted in down-regulation of gene expression of MHC molecules
at all the time points post-inoculation. Table 21 summarizes the
responses or expression of TLR and MHC genes upon interaction
of MAP with several host systems [79–86]. The MHC down-
regulation has also been demonstrated to occur in in vitro grown
macrophages (as early as 12 hr post-infection), as well as, in
macrophages isolated from subclinical and clinical phase of
infection [7,87,88]. Thus, it is plausible that the down-regulation
of the MHC molecules observed in the present study at the Early
Phase of infection initiates and facilitates permanently persistent
MAP infections. Given the role of MHC molecules in triggering
the Th cells, the down-regulation of MHC during the establish-
ment of MAP infection may block the effector arms of immune
system. This irreversible down-regulation of MHC expression may
contribute at some level to the paucity of T-cell infiltrates and
tubercle formation observed in Johne’s disease lesions [89].
Other Mechanistic Genes of Interest
Expression levels of keratinocyte growth factor (KGF), insulin-
like growth factor-1 (IGF secreted by intraepithelial lymphocytes)
and macrophage-derived factors were highly up-regulated during
the Late Phase of infection. Several genes that encode for
antimicrobial mechanisms against any invading pathogens were
down-regulated in the MAP infection. These included nitric oxide
synthase (endothelial as well as hepatic), dipepdidyl-peptidase, and
dihydrofolate reductase (DHFR) at all the time points. DHFR is critical
for nitric oxide bioavailability in bovine aortic endothelium cells
[90].
Host Immune Tolerance by Antigen Mimicry
Immune tolerance can also be induced via antigen mimicry. In
Crohn’s patients, amino acid similarities between MAP and
intestinal proteins was examined in detail [91]. Auto-reactive
lymphocytes specific for glutathione peroxidase participate in the
decreased activity of this enzyme observed in Crohn’s disease
patients. This in turn could lead to an imbalanced and inefficient
endogenous antioxidant response in the intestinal mucosa of
Figure 7. Effect of siRNA Knock-down of MAPK1 on the
Invasion of HeLa cells by MAP. HeLa cells were transfected with
Glyceraldehyde 3 phosphate dehydrogenase (GAPDH), mitogen acti-
vated protein kinase 1 (MAPK1), and Epithelial Growth Factor Receptor
(EGFR) siRNAs, infected with MAP, and measured for the effects on
invasion. Invasion is given as a percentage relative to the negative
control that consisted of HeLa cells incubated with transfecting reagent
in serum free medium.
doi:10.1371/journal.pone.0042127.g007
Table 17. Strongly Down-Regulated Mechanistic Genes of the One Carbon Pool by Folate Pathway.
MTHFD1 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1,
methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase1
This gene encodes a protein that possesses three distinct
enzymatic activities, 5,10-methylenetetrahydrofolate
dehydrogenase, 5,10-methenyltetrahydrofolate
cyclohydrolase and 10-formyltetrahydrofolate synthetase.
MTHFD2 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2,
methenyltetrahydrofolate cyclohydrolase
This gene encodes a nuclear-encoded mitochondrial
bifunctional enzyme with methylenetetrahydrofolate
dehydrogenase and methenyltetrahydrofolate
cyclohydrolase activities. The enzyme functions as a
homodimer and is unique in its absolute requirement for
magnesium and inorganic phosphate.
GART phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase,
phosphoribosylaminoimidazole synthetase
Encodes a trifunctional polypeptide. It has
phosphoribosylglycinamide formyltransferase,
phosphoribosylglycinamide synthetase,
phosphoribosylaminoimidazole synthetase activity which
is required for de novo purine biosynthesis.
doi:10.1371/journal.pone.0042127.t017
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Crohn’s disease patients. Further studies are warranted to
understand if a similar kind of antigen mimicry occurs in Johne’s
disease.
Biological System Level Modeling
A biological system model of the host response to MAP infection
was created from the merger of 14 overlapping pathways that were
considered to be major players in the host immune tolerance as
identified and described above. Figure 9 depicts our conceptual
holistic model of the interplay between pathways. This figure
illustrates only a portion of the complex interplay that may be
occurring as MAP subverts and hi-jacks different host biological
processes. The actual systems Bayesian network is comprised of
433 genes constructed from known biological relationships
contained in the overlapping pathways and resulted in a very
dense network model as illustrated in Figure 10. This system-level
Table 18. Key Mechanistic Genes of the Long-term Potentiation and Long-term Depression Pathways.
Early Phase Down-Regulated Genes
PPP1CA protein phosphatase 1, catalytic subunit,
alpha isozyme1
Encodes one of the three catalytic subunits of protein phosphatase 1 (PP1). PP1 is a serine/
threonine specific protein phosphatase known to be involved in the regulation of a variety of
cellular processes, such as cell division, glycogen metabolism, muscle contractility, protein
synthesis, and HIV-1 viral transcription. Increased PP1 activity has been observed in the end stage
of heart failure. Studies in both human and mice suggest that PP1 is an important regulator of
cardiac function.
PPP1CB protein phosphatase 1, catalytic subunit,
beta isozyme1
Same as PPP1CA above
MAPK1 mitogen-activated protein kinase 11 Encodes a member of the MAP kinase family. MAP kinases, also known as extracellular signal-
regulated kinases (ERKs), act as an integration point for multiple biochemical signals, and are
involved in a wide variety of cellular processes such as proliferation, differentiation, transcription
regulation and development. Involved in both the initiation and regulation of meiosis, mitosis,
and postmitotic functions in differentiated cells by phosphorylating a number of transcription
factors such as ELK1. Phosphorylates EIF4EBP1; required for initiation of translation.
GNAI3 guanine nucleotide binding protein (G protein),
alpha inhibiting activity polypeptide 3
Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in
various transmembrane signaling systems.
GNAO1 guanine nucleotide binding protein (G protein),
alpha activating activity polypeptide O
Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in
various transmembrane signaling systems. The G(o) protein function is not clear.
IGFR1 insulin-like growth factor 1 receptor1 This receptor binds insulin-like growth factor with a high affinity. It has tyrosine kinase activity.
The insulin-like growth factor I receptor plays a critical role in transformation events. IGFRs
mediate their intracellular actions through the PI 3-K and RAS/RAF/MAPK signaling pathways and
downstream effectors include mTOR, p70 S6 kinase, ERK and JNK. Many tumors have altered
expression of IGF1R and its ligands and this constitutes an early, possible initiating, event in
tumorigenesis.
Gucy2c guanylate cyclase 2C (heat stable enterotoxin
receptor
Receptor for the E.coli heat-stable enterotoxin (E.coli enterotoxin markedly stimulates the
accumulation of cGMP in mammalian cells expressing GC-C). Also activated by the endogenous
peptide guanylin.
doi:10.1371/journal.pone.0042127.t018
Table 19. Key Down-Regulated Mechanistic Genes of the CCR3 Signaling in Eosinophil Pathway.
GNAQ guanine nucleotide binding protein (G protein), q polypeptide1 The encoded protein, an alpha subunit in the Gq class,
couples a seven-transmembrane domain receptor to
activation of phospolipase C-beta. Mutations at this locus
have been associated with problems in platelet activation
and aggregation.
MAP2K1 mitogen-activated protein kinase kinase 1 Encodes a member of the dual specificity protein kinase
family, which acts as a mitogen-activated protein (MAP)
kinase kinase. MAP kinases, also known as extracellular
signal-regulated kinases (ERKs), act as an integration point
for multiple biochemical signals. As an essential
component of MAP kinase signal transduction pathway,
this kinase is involved in many cellular processes such as
proliferation, differentiation, transcription regulation and
development.
MYL2 myosin, light chain 2, regulatory, cardiac, slow1 encodes the regulatory light chain associated with cardiac
myosin beta (or slow) heavy chain. Ca+ triggers the
phosphorylation of regulatory light chain that in turn
triggers contraction. Myosins are a large family of motor
proteins that share the common features of ATP
hydrolysis, actin binding and potential for kinetic energy
transduction.
doi:10.1371/journal.pone.0042127.t019
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Table 20. Bayesian z-Score Values of Genes Involved in the Activation of CD40 Molecule.
Symbol Description t = 30 t = 60 t = 120 t = 240 t = 480 t =720
TRAF6 TNF receptor-associated factor 6 1.01 0.07 1.65 0 0 22.16
TRAF3 TNF receptor-associated factor 3 0 0 0 0 20.76 0.92
TNFAIP3 Tumor necrosis factor, alpha-induced protein 3 21.58 0 1.88 0 20.54 21.08
NFKBIA Nuclear factor of kappa light polypeptide gene
enhancer in B-cells inhibitor, alpha
0.79 20.38 21.71 21.33 20.26 2.12
NFKB1 Nuclear factor of kappa light polypeptide gene
enhancer in B-cells 1 (p105)
21.47 0 0 20.59 22.6 2.25
MAP3K14 Mitogen-activated protein kinase kinase kinase 14 1.31 20.22 20.65 20.35 20.45 0
MAP3K1 Mitogen-activated protein kinase kinase kinase 1 2.74 0 22.83 22.58 4.83 22.24
IKBKG Inhibitor of kappa light polypeptide gene enhancer in
B-cells, kinase gamma
20.14 0 0 0 21.6 0.66
IKBKB Inhibitor of kappa light polypeptide gene enhancer in
B-cells, kinase beta
0 0.31 20.43 21.63 0 1.17
IKBKAP Inhibitor of kappa light polypeptide gene enhancer in
B-cells, kinase complex-associated protein
1.74 0 2.41 0.31 20.37 0
DUSP1 Dual specificity phosphatase 1 1.69 0.65 1.81 0 0 2.4
CHUK Conserved helix-loop-helix ubiquitous kinase 0 0 0.69 0.17 0 20.66
t = time (in minutes) post-infection.
doi:10.1371/journal.pone.0042127.t020
Figure 8. T-Cell Receptor Signaling Pathway Network Model and T-Cell Signaling Pathway Scores. The model (a) and the heat map (b)
indicate an overall lack of differential expression that reflects a defective host immune response state to MAP in bovine Peyer’s patch. A defective
antigen processing and presentation by MHC class II molecule and lack of immune response is readily evident by examining the network (a) and the
Bayesian z-score heat map (b).
doi:10.1371/journal.pone.0042127.g008
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network was interrogated to identify genes and key regulatory
points (hubs) that are purported to be governing the host response
to MAP. Since the model is trained by the host-pathogen response
data, the computational nature of the dynamic Bayesian networks
permits interrogation of the model both computationally and
visually to identify correlated relationships and candidate regulator
hubs that are potential targets for immune and/or therapeutic
intervention. Table 22 illustrates the interrogation of the model for
highly correlated downstream gene relationships for the important
regulatory gene AKT3. AKT3 was identified as a key mechanistic
Table 21. Summary Review of MAP-Induced TLR and MHC Responses.
Infection Model Expression level Reference
Blood samples from four MAP exposed and four unexposed cattle Unconfirmed association between MAP exposure and in-vivo MHC
gene modulation
[83]
In silico analysis, for a population-based genetic association of a Spanish
Holstein-Friesian sample
3 tightly linked SNP in TLR4 were found to be associated with
susceptibility to MAP infection
[84]
Early paucibacillary MAP infection compared to multibacillary MAP infection
in sheep
Lower expression levels of most TLRs in paucibacillary group than
the multibacillary group
[85]
MAP infected monocyte-derived dendritic cells Unable to present antigen via MHC class II [82]
In vitro infection of Chinese Hamster Ovary (CHO) cells with MAP Low TLR4 [81]
Peripheral blood derived macrophages from juvenile sheep Down-regulation of MHC class I and II [80]
Bovine macrophages infection (in-vitro) with MAP Down-regulation of MHC class I and class II molecules [86]
Intestinal macrophages in clinically infected sheep compared with normal
tissues
Lower expression of MHC class II [79]
doi:10.1371/journal.pone.0042127.t021
Figure 9. High Level Conceptual Systems Network of Interrelated Pathways further Defining the Bovine Host Immune Tolerance to
MAP. Each box that defines specific pathways has its temporal heat map scores to document the dynamic state of the pathway (see figure legend).
The arrows connecting the pathways are drawn to represent possible causal relationships between the pathways.
doi:10.1371/journal.pone.0042127.g009
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gene and a gene with high overlap with multiple pathways.
Ultimately, the diversion of the host gene response to benefit the
pathogen depends on the activation of different genes in a
particular pathway. This system model enabled a broader
examination of the interrelated pathway-host response that we
could not have otherwise identified from traditional statistical
analysis methods. Further interrogation of the system model led to
the identification of several mechanistic genes that have high
positive correlated relationships and influence on downstream
genes that included: LEPR-.Ppara, LEP-.Stk11, SOCS3-.JAK1,
SOCS3-.Irs2, STAT1-.CXCL10, STAT3-Prkag2, MAP3K8-
.MAP3K14, NFKB1-.IFNA13, NFKB2-.TNF, JAK1-.PTPN11,
IFNAR2-.STAT1, MAP3K14-.IKBKB, TNF-.TNFRSF1A, and
NFKBIA-.NFKBIB. Some of the more dominating negative
correlated relationships included: NFKB1-.IL8, STAT3-.POMC,
NFKB1-.SOCS3, NFKB1-.IL12B, NFKB1-.CXCL10, and LEPR-
.CAMKK2. The identification of these relationships provides
important insight into possible points of interaction between MAP
and the host and novel points of intervention.
Figure 10. System Bayesian Network Model of Host Immune Tolerance. Fourteen pathways were used to construct the network developed
from temporal in vivo host transcriptome data of MAP infected bovine Peyer’s patch. The full network model is shown on the bottom figure. A
magnified section of the model is shown in the top figure. Mechanistic genes are shown with orange rings. A few important mechanistic genes and
arcs (gene-to-gene relationships) are indicated on the magnified view. The thickness of the arcs and their color indicates the strength of positive or
negative correlation between the interconnected genes. Some of the pathway arcs are labled: +p=phosphorylation; 2p=dephosphorylation;
+u=ubiquitination; +m=methylation; e = expression;c = compound; and b=binding and unlabeled connecting arc implies activation.
doi:10.1371/journal.pone.0042127.g010
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Conclusions
The temporal in vivo host global gene expression analysis of the
MAP infected major target organ in the target animal species
provides unique opportunities to systematically identify and define
the complexities of major pathways influencing the pathogenesis of
Johne’s Disease, particularly during the early, intermediate and
late phase responses in the first 12 hours post-infection. Our
Bayesian analysis and modeling of host gene expression data
considerably strengthen the hypothesis that MAP subverts the
bovine host innate and adaptive immune responses toward
immune tolerance. More specifically, we identified no less than
ten major cellular pathways that were subverted to reduce host
cellular uptake and phagocytosis of MAP one of which is
supported by our in vitro RNAi silencing of the mechanistic
MAPK1 gene resulting in highly significant reduced invasion of
MAP. Furthermore, our analyses disclosed that MAP compro-
mised the host mucosal immune barrier by manipulating the
major mechanistic genes of the junction (gap, tight, adherens), cell
adhesion molecules – intergrin mediated pathways, and the trefoil
factor initiated mucosal healing pathway, adding credibility that
the MAP induced decreased trans-epithelial resistance as revealed
in our in vitro model and likely has considerable in vivo significance.
Finally, we created a robust biological system model of the bovine
host response to MAP infection facilitating computational and
visual interrogation of the model to identify several potential
targets for intervention. We demonstrated that the systems biology
approach not only facilitated observations of a holistic functional
picture of early responses to MAP, but also uncovered new
pathways reinforcing immune tolerance while identifying mech-
anistic pathways compromising the enteric mucosal immune
barrier during colonization of Peyer’s patch by MAP.
Supporting Information
Figure S1 Significantly Perturbed Pathways of All
Phases. This heat map figure shows all scored pathways meeting
a 97.5% confidence threshold at any time point and contains the
same pathways as listed in Tables 2, 3 and 4. Starting at the left
hand column top pathway, the order of the pathways are from the
highest activated pathway score (i.e., Parkinson’s Disease highest
score at t = 30 min.) to the most suppressed pathway score (i.e.,
Thiamine metabolism lowest score at t = 720 min.) in the bottom
right column. In this figure, the pathway scores are shown as
darker red gradients indicating higher activation scores (more up-
regulated gene expression within the pathway gene set) while the
darker green gradients indicating more suppressed pathway
activity (more down-regulated gene expression). Grey is near a
zero score and black is equal to a zero score.
(DOC)
Table S1 Significantly Perturbed GO Categories for
Early Phase Response. List of significantly perturbed gene
ontology categories of biological processes for the Early Phase time
period (30 and 60 minutes post-infection). Scores are determined
by Dynamic Bayesian Gene Group Activation technique as
explained in the text.
(XLS)
Table S2 Significantly Perturbed GO Categories for
Intermediate Phase Response. List of significantly perturbed
Table 22. Illustrative Interrogation of the Model for Mechanistic AKT3 Gene Downstream Regulatory Effects on Multiple Pathways.
Start Gene Start Gene Description
Normalized
Correlation
Weight End Gene End Gene Description Relationship
AKT3 V-akt murine thymoma viral oncogene
homolog3 (protein kinase B, gamma)
20.425 NFkB1 Nuclear factor of kappa light polypep-
tide gene enhancer in B cells 1
Phosphorylation
NFkB1 Nuclear factor of kappa light polypeptide
gene enhancer in B cells 1
20.143 CXCL-10 Chemokine (C-X-C motif) ligand 10 Indirect
NFkB1 Nuclear factor of kappa light polypeptide
gene enhancer in B cells 1
20.18 IL-12B Interleukin 12B (NK cell stimulator
factor 2), Cytotoxic lymphocyte
maturation factor 2
Indirect
NFkB1 Nuclear factor of kappa light polypeptide
gene enhancer in B cells 1
20.185 SOCS3 Suppressor of cytokine signaling 3 Expression
NFkB1 Nuclear factor of kappa light polypeptide
gene enhancer in B cells 1
20.123 IL-6 Interleukin 6 Indirect
SOCS3 Suppressor of Cytokine Signalling 3 0.389 JAK1 Janus Kinase 1 (a protein tyrosine
kinase)
Inhibition
SOCS3 Suppressor of Cytokine Signalling 3 0.257 Irs2 AGENCOURT_7772254 NIH_MGC_92
cDNA clone IMAGE:6014829 59
Inhibition
SOCS3 Suppressor of Cytokine Signalling 3 0.125 LEPR Leptin Receptor Inhibition
JAK1 Janus kinase 1 (a protein tyrosine kinase) 0.179 PTPN11 Protein tyrosine phosphate,
non-receptor type 11
Phosphorylation
LEPR Leptin Receptor 0.484 Ppara Peroxisome proliferator activated
receptor alpha
Activation
LEPR Leptin Receptor 0.243 Stk11 Serine/threonine kinase 11
LEPR Leptin Receptor 0.159 Camkk1 Calcium/Calmodulin-dependent
protein kinase kinase 1, alpha
LEPR Leptin Receptor 0.141 Camkk2 Calcium/Calmodulin-dependent
protein kinase kinase 1, beta
Activation
doi:10.1371/journal.pone.0042127.t022
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gene ontology categories of biological processes for the Interme-
diate Phase time period (120, 240, and 480 minutes post-
infection). Scores are determined by Dynamic Bayesian Gene
Group Activation technique as explained in the main text.
(XLS)
Table S3 Significantly Perturbed GO Categories for
Late Phase Response. List of significantly perturbed gene
ontology categories of biological processes for the Late Phase time
period (720 minutes post infection). Scores are determined by
Dynamic Bayesian Gene Group Activation technique as explained
in the main text.
(XLS)
Table S4 Mechanistic Genes Identified by Dynamic
Bayesian Modeling. State of modulation is indicated by the
‘‘+’’ for up-regulation and ‘‘2’’ for down-regulation.
(XLS)
Table S5 Mechanistic Gene Cross-Talk. This Table
provides list of mechanistic genes for 43 pathways involved in
signaling and immune response. Several mechanistic genes are
associated in multiple pathways that may be the source of cross-
talk, and thus, have more significant influence governing the host
immune tolerance to MAP. Of the 43 pathways analyzed, 36
pathways had at least one overlapping mechanistic gene. It was
found that 141 mechanistic genes had overlaps within the 36
pathways examined.
(XLS)
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